Professional Documents
Culture Documents
July update
1. List of Reference Authorities
Other 2. List of drug regulatory agencies of
746 documents/Văn countries on the SRA list.
bản khác 3. List of drug regulatory agencies of
countries that are PIC/s and ICH
member countries
LIST OF PHARMACEUTICAL
Other
MANAGEMENT AGENCIES OF
733 documents/Văn
COUNTRIES THAT IS MEMBERSHIP
bản khác
PIC/s AND ICH
Other
731 documents/Văn List of reference Authorities
bản khác
Resolution 61/NQ-CP in 2021 on the
purchase of COVID-19 vaccine
Resolution/Nghị
730 61/NQ-CP AZD1222 produced by AstraZeneca by
Quyết
Vietnam Vaccine Joint Stock Company
issued by the Government
Decision/Quyết
519 155/QĐ-BYT
định
Official 4469/BTP-
496
letter/Công văn PLQT
List of Branded
495 List of Branded PI verion 1
PI
Decision/Quyết
494 5252/QĐ-BYT
định
Decision/Quyết
493 5074/QD-BYT
định
Official
492 18438/QLD-CL
letter/Công văn
Official
491 16813/QLD-CL
letter/Công văn
Official 16324/QLD-
489
letter/Công văn KD
Decision/Quyết
488 4043/QĐ-BYT
định
Integrated
06/VBHN- Joint Circular 13 and 18 guiding on
478 document/Văn
BNNPTNT veterinary drug management
bản hợp nhất
Circular 18/2019/TT-BYT dated July 17,
Circular/Thông 18/2019/TT- 2019 guiding on Good Manufacturing
477
tư BYT Practices (GMP) in the production and
trading of health supplements
Circular/Thông 08/2019-TT-
469
tư BYT
Other
463 documents/Văn
bản khác
Official 229/YDCT-
462
letter/Công văn QLHN
Other
461 documents/Văn
bản khác
Integrated
457 document/Văn 10/VBHN-BYT
bản hợp nhất
Decision/Quyết
454 1181/QĐ-BYT
định
Circular/Thông 03/2019/TT-
452
tư BYT
Other
449 documents/Văn
bản khác
Other
434 documents/Văn Price Declaration
bản khác
Decree No. 169/2018/ND-CP dated
Decree/Nghị 169/2018/NĐ- December 31, 2018 amendments to
433
định CP Decree No. 36/2016/ND-CP on medical
device management
Circular/Thông 18/2018/TT-
402
tư BYT
Official 106/TTMS-
393
letter/Công văn NVĐT
Official
392 8590/QLD-KD
letter/Công văn
Circular/Thông 11/2018/TT-
389 Circular No. 11/2018/TT-BYT dated May
tư BYT
4, 2018 on Drug/Drug Ingredient Quality
Circular/Thông 10/2018/TT-
388
tư BYT
Decision/Quyết
387 2710/QĐ-BYT
định
Official
385 6964/QLD-ĐK
letter/Công văn
Official
384 7002/QLD-ĐK
letter/Công văn
Official
383 7063/QLD-ĐK
letter/Công văn
Official
382 6777/QLD-MP
letter/Công văn
Official
381 6477/QLD-ĐK
letter/Công văn
Official 1567/BYT-TB-
374
letter/Công văn CT
Official 1511/TCHQ-
373
letter/Công văn GSQL
Official
372 4430/QLD-ĐK
letter/Công văn
Official
371 4338/QLD-PC
letter/Công văn
Official 7370/BYT-TB-
359
letter/Công văn CT
Official 7371/BYT-TB-
358
letter/Công văn CT
Official 21508/QLD-
356
letter/Công văn ĐK
Decision/Quyết 3105/QĐ-
355
định BHXH
Circular No. 46/2017/TT-BYT dated
Circular/Thông 46/2017/TT- December 15, 2017 guidelines
354
tư BYT 36/2016/ND-CP on management of
medical equipment
Official 7165/BYT-TB-
353
letter/Công văn CT
Official 20297/QLD-
351
letter/Công văn GT
Decision/Quyết
350 5358/QĐ-BYT
định
Official 19529/QLD-
349
letter/Công văn ĐK
Circular/Thông 43/2017/TT-
348
tư BYT
Circular/Thông 42/2017/TT-
344
tư BYT
Circular/Thông 114/2017/TT-
342
tư BTC
Official
341 15466/QLD-TT
letter/Công văn
Official 5464/BYT-TB-
340
letter/Công văn CT
Official 5278/BYT-TB-
339
letter/Công văn CT
Official 14433/QLD-
338
letter/Công văn ĐK
Official 14434/QLD-
337
letter/Công văn ĐK
Official 12595/QLD-
336
letter/Công văn KD
Official
333 9436/QLD-KD
letter/Công văn
Official 3608/BYT-TB-
332
letter/Công văn CT
Official
321 5751/QLD-ĐK
letter/Công văn
Official 1902/BYT-
319
letter/Công văn QLD
Official
318 4533/QLD-ĐK
letter/Công văn
Official 1527/BYT-TB-
316
letter/Công văn CT
Official
315 454/BYT-QLD
letter/Công văn
Official 5271/BHXH-
314
letter/Công văn DVT
Official 8991/BYT-
313
letter/Công văn KHTC
Official
312 7841/ATTP-PC
letter/Công văn
Decision/Quyết
311 7115/QĐ-BYT
định
REGULATION ON RECOGNITION OF
Circular/Thông 42/2016/TT-
310 MEDICAL DEVICE CLASSIFICATION
tư BYT
RESULTS
Circular No. 277/2016/TT-BTC dated
November 14, 2016, on amounts,
Circular/Thông 277/2016/TT-
309 collection, payment, management and
tư BTC
use of fees in the fields of pharmacy
and cosmetics
Official 19197/QLD-
304
letter/Công văn ĐK
Decision/Quyết
303 5539/QĐ-BYT
định
Official 18274/QLD-
302
letter/Công văn ĐK
Official 18275/QLD-
301
letter/Công văn ĐK
Official 18276/QLD-
300
letter/Công văn ĐK
Official
299 17804/QLD-TT
letter/Công văn
Official 17702/QLD-
298
letter/Công văn ĐK
Official 16315/QLD-
297
letter/Công văn KD
Official 16342/QLD-
296
letter/Công văn KD
Decision/Quyết
295 4554/QĐ-BYT
định
Decision/Quyết
294 4288/QĐ-BYT
định
Official 13392/QLD-
293
letter/Công văn ĐK
Official 12973/QLD-
292
letter/Công văn ĐK
Official
291 12597/QLD-TT
letter/Công văn
Circular/Thông 17/2016/TT-
287
tư BYT
Decision/Quyết
286 2660/QĐ-BYT
định
Decision/Quyết
285 2659/QĐ-BYT
định
Circular/Thông 12/2016/TT-
281
tư BYT
Circular/Thông 11/2016/TT-
280
tư BYT
Official 2577/BYT-
279
letter/Công văn QLD
Circular/Thông 09/2016/TT-
278
tư BYT
Circular/Thông 10/2016/TT-
277
tư BYT
Official
276 6257/QLD-ĐK
letter/Công văn
Decision/Quyết
275 1348/QĐ-BYT
định
Decision/Quyết
273 1231/QĐ-BYT
định
Decision/Quyết
272 1122/QĐ-BYT
định
Decision/Quyết
271 16/QĐ-K2ĐT
định
Official
270 3447/QLD-TT
letter/Công văn
Official
267 2926/QLD-VP Update warnings on APIs
letter/Công văn
Other
266 documents/Văn
bản khác
Other
265 documents/Văn
bản khác
Official
259 22982/QLD-TT
letter/Công văn
Other
258 documents/Văn
bản khác
Circular No. 46/2015/TT-BYT dated
December 01, 2015, on introduction of
Circular/Thông 46/2015/TT-
257 National Technical Regulation on Food
tư BYT
Flavoring - Vanilla Flavouring
Substances
Circular No. 47/2015/TT-BYT dated
Circular/Thông 47/2015/TT- December 01st 2015, on the national
256
tư BYT technical regulation on food processing
aids - solvents
Decision/Quyết
254 5084/QĐ-BYT
định
Other
Asean Guideline for Cosmetics Good
251 documents/Văn
Manufacturing Practices
bản khác
Official 20257/QLD-
250
letter/Công văn ĐK
Decision/Quyết
246 3970/QĐ-BYT
định
Official 15221/QLD-
245
letter/Công văn TTra
Official 15002/QLD-
244
letter/Công văn MP
Decision/Quyết
243 442/QĐ-QLD
định
Official 14167/QLD-
242
letter/Công văn ĐK
Other
241 documents/Văn
bản khác
Decision/Quyết
240 423/QĐ-QLD
định
Official 13884/QLD-
239
letter/Công văn MP
Official 189/YDCT-
238
letter/Công văn QLD
Joint circular No. 16/2015/TTLT-BYT-
Joint BTC dated July 2, 2015, on
16/2015/TTLT-
237 Circular/Thông amendments to Clause 5 Article 3 of
BYT-BTC
tư liên tịch Joint circular No. 41/2014/TTLT-BYT-
BTC on guidelines for health insurance
Official 10762/QLD-
236
letter/Công văn MP
Official 10545/QLD-
235
letter/Công văn ĐK
Official 3999/BYT-
234
letter/Công văn QLD
Official 10107/QLD-
233
letter/Công văn ĐK
Circular/Thông 13/2015/TT-
231
tư BYT
Official 3309/BYT-TB-
229
letter/Công văn CT
Official
228 9234/QLD-ĐK
letter/Công văn
Official
227 8762/QLD-TT
letter/Công văn
Official
226 8185/QLD-ĐK
letter/Công văn
Decision/Quyết
224 1738/QĐ-BYT
định
Official 2433/BYT-
223
letter/Công văn QLD
Official
220 5543/QLD-ĐK
letter/Công văn
Official
219 5131/QLD-CL
letter/Công văn
Other
Materials for evaluation of drug
218 documents/Văn
registration dossier
bản khác
Official
217 5078/QLD-ĐK
letter/Công văn
Decision/Quyết
214 101/QĐ-QLD
định
Official
213 1209/QLD-CL
letter/Công văn
Official 21501/
210 Guiding on review registration dossiers
letter/Công văn QLD_ĐK
Integrated
204 document/Văn 11/VBHN-BYT
bản hợp nhất
Official 19098/QLD-
203
letter/Công văn ĐK
Official 18671/QLD-
202
letter/Công văn ĐK
Official 18672/QLD-
201
letter/Công văn ĐK
34/2014/TTLT-
Joint Guidance on the labeling of goods for
BYT-
200 Circular/Thông foods, food additives, and packaged
BNNPTNT-
tư liên tịch food processing aids
BCT
Official 16734/QLD-
199
letter/Công văn ĐK
Official 16751/QLD-
198
letter/Công văn ĐK
Official 16752/QLD-
197
letter/Công văn ĐK
Official 12802/QLD-
192
letter/Công văn ĐK
Joint
24/2014/TTLT-
191 Circular/Thông
BYT-BTC
tư liên tịch
Decision/Quyết
190 2535/QĐ-BYT
định
Integrated
189 document/Văn 09/VBHN-BYT
bản hợp nhất
Official 11393/QLD-
188
letter/Công văn ĐK
Circular/Thông 23/2014/TT-
187 promulgation of list of otc drugs
tư BYT
Official 10896/QLD-
186
letter/Công văn ĐK
Official 11039/QLD-
183
letter/Công văn ĐK
Law No. 46/2014/QH13 dated June 13,
182 Law/Luật 46/2014/QH13 2014, amendments to the Law on
Health insurance
Official
181 9049/QLD-ĐK
letter/Công văn
Decision/Quyết
178 1830/QĐ-BYT
định
Decision/Quyết
177 1730/QĐ-BYT Decision No. 1730/QD-BYT dated May 16, 2014, promulgati
định
Other
175 documents/Văn
bản khác
Other
174 documents/Văn
bản khác
Decision/Quyết
172 1129/QĐ-BYT
định
Official
171 4822/QLD-ĐK
letter/Công văn
Official
170 4764/QLD-ĐK
letter/Công văn
Official
169 4810/QLD-ĐK
letter/Công văn
PROVIDING GUIDANCE ON
Circular/Thông 12/2014/TT-
168 MANAGEMENT OF VACCINE USAGE
tư BYT
IN VACCINATION
Official
167 3637/QLD-TT
letter/Công văn
Official
166 3256/QLD-CL
letter/Công văn
Official
165 17/YDCT_QLD
letter/Công văn
Integrated
162 document/Văn 01/TTHN-BYT
bản hợp nhất
Official 8600/BYT-
159
letter/Công văn QLD
Circular/Thông 45/2013/TT-
158
tư BYT
Official
157 20806/QLD-TT
letter/Công văn
Circular No. 10/2013/TT-BVHTTDL of
December 06, 2013, detailing and
Circular/Thông 10/2013/TT- guiding implementation of Law on
156
tư BVHTTDL advertising and Decree No.
181/2013/ND-CP implementation of Law
on advertising
Official 20614/QLD-
155
letter/Công văn KD
Official 19799/QLD-
154
letter/Công văn ĐK
Circular/Thông 40/2013/TT-
153
tư BYT
Circular/Thông 38/2013/TT-
152
tư BYT
Circular/Thông 39/2013/TT-
151
tư BYT
Decree/Nghị 176/2013/NĐ-
149
định CP
Joint
36/2013/TTLT- Guiding the bidding for medicine
148 Circular/Thông
BYT-BTC purchase by medical eshtablishments
tư liên tịch
Official 17560/QLD-
144
letter/Công văn ĐK
Official 17561/QLD-
143
letter/Công văn ĐK
Integrated
07/2013/
142 document/Văn
TTHN-BYT
bản hợp nhất
Decision/Quyết
141 02/QĐHN-BYT
định
Integrated
140 document/Văn 05/TTHN-BYT
bản hợp nhất
Guiding temporarily the extension of
Official 5890/BYT- registration numbers and duration for
139
letter/Công văn QLD submitting dossier of re-registration
Official 15115/QLD-
137
letter/Công văn ĐK
Official
136 13719/QLD-CL Quality examination of import drugs
letter/Công văn
Official 11147/QLD-
132
letter/Công văn ĐK
Decision/Quyết 42/2013/QĐ-
131
định TTg
Other
130 documents/Văn QT.QLD.56
bản khác
Official
129 8121/QLD-CL
letter/Công văn
Decision/Quyết 1387/2013/
126
định QD-BYT
Circular/Thông 08/2013/TT-
125
tư BCT
Integrated
06/2013/
124 document/Văn
TTHN-BYT
bản hợp nhất
Official Updating the pharmacological
123 5074/QLD-ĐK
letter/Công văn information of statin drugs
Circular/Thông 10/2013/TT-
122
tư BYT
Circular/Thông 03/2013/TT-
119
tư BTC
Circular/Thông 33/2012/TT-
118
tư BYT
Official
117 20215/QLD-CL
letter/Công văn
Official 19109/QLD-
116
letter/Công văn ĐK
Official 18614/QLD-
115
letter/Công văn ĐK
Official 15226/QLD-
113
letter/Công văn ĐK
Official 14975/QLD-
112
letter/Công văn ĐK
Official 13702/QLD-
110
letter/Công văn ĐK
Official 13703/QLD-
109
letter/Công văn ĐK
Official 13704/QLD-
108
letter/Công văn ĐK
Official 13705/QLD-
107
letter/Công văn ĐK
Official 13706/QLD-
106
letter/Công văn ĐK
Official 13708/QLD-
104
letter/Công văn ĐK
Official 13663/QLD-
103
letter/Công văn ĐK
Decision/Quyết
102 219/QĐ-QLD
định
Decree/Nghị 63/2012/ND-
101
định CP
Circular/Thông 14/2012/TT-
100
tư BYT
Decision No. 2962/QD-BYT of August
22, 2012, on promulagting temporary
regulation on documents need supply in
Decision/Quyết order to announce lists of original
99 2962/QĐ-BYT
định proprietary medicines, medicines used
for treatment similar with original
proprietary medicines, medicines with
documents proving bioequivalence
Official
98 9668/QLD-ĐK
letter/Công văn
Other
95 documents/Văn
bản khác
Circular/Thông 10/2012/TT-
94
tư BYT
Official
93 5865/QLD-ĐK
letter/Công văn
Official
92 5866/QLD-ĐK
letter/Công văn
Official
91 5867/QLD-ĐK
letter/Công văn
Official
90 5868/QLD-ĐK
letter/Công văn
Official
89 5869/QLD-ĐK
letter/Công văn
Official
88 4995/QLD-ĐK
letter/Công văn
Official
87 4996/QLD-ĐK
letter/Công văn
Official
86 4614/QLD-ĐK
letter/Công văn
Official
85 4396/QLD-ĐK
letter/Công văn
Official
84 4397/QLD-ĐK
letter/Công văn
Official
83 4398/QLD-ĐK
letter/Công văn
Joint
01/2012/TTLT-
80 Circular/Thông Bidding
BYT-BTC
tư liên tịch
Joint
50/2011/TTLT-
79 Circular/Thông
BYT-BTC-BCT
tư liên tịch
Circular/Thông 45/2011/TT-
78
tư BYT
Official 12746/QLD-
73
letter/Công văn ĐK
Official 10638/QLD-
72
letter/Công văn KD
Official
71 9992/QLD-ĐK
letter/Công văn
Circular/Thông 31/2011/TT-
70
tư BYT
on management of insecticidal or
Circular/Thông 29/2011/TT-
69 germicidal chemicals and preparations
tư BYT
for household and medical use
Circular/Thông 24/2011/TT-
68
tư BYT
Circular/Thông 16/2011/TT-
66
tư BYT
Official
65 3886/QLD-ĐK
letter/Công văn
Official
64 3887/QLD-ĐK
letter/Công văn
Official 1466/BYT-
63
letter/Công văn QLD
Official
62 1479/QLD-TT
letter/Công văn
Decision/Quyết
58 3759/QĐ-BYT
định
Official
57 6945/QLD-ĐK
letter/Công văn
Official
55 5678/QLD-ĐK
letter/Công văn
Circular/Thông 10/2010/TT-
54
tư BYT
Circular/Thông 11/2010/TT-
53
tư BYT
Official
52 4246/QLD-ĐK
letter/Công văn
Circular/Thông 09/2010/TT-
51
tư BYT
Official
49 3609/QLD-ĐK
letter/Công văn
Circular/Thông 04/2010/TT-
47
tư BYT
Circular/Thông 02/2010/TT-
46
tư BYT
Circular/Thông 22/2009/TT-
45
tư BYT
Circular/Thông 13/2009/TT-
44
tư BYT
Circular/Thông 08/2009/TT-
43
tư BYT
Official
42 2224/QLD-TT Guiding on ADR report
letter/Công văn
Joint 85/2008/TTLT-
41 Circular/Thông BVHTTDL-
tư liên tịch BTTTT
Decision/Quyết 39/2008/QĐ-
40
định BYT
Official 12048/QLD-
39
letter/Công văn ĐK
Decision/Quyết 59/2008/QD-
38
định BTC
Circular/Thông 04/2008/TT-
37
tư BYT
Decision/Quyết 05/2008/QĐ-
36
định BYT
Official
35 341/QLD-ĐK
letter/Công văn
Decision/Quyết 41/2007/QĐ-
34
định BYT
Decision/Quyết 151/2007/QD-
33
định TTG
Joint
11/2007/TTLT-
32 Circular/Thông
BYT-BTC-BCT
tư liên tịch
Joint
10/2007/TTLT-
31 Circular/Thông
BYT-BTC
tư liên tịch
Decision/Quyết 10/2007/QĐ-
30
định BTM
Official
29 2286/QLD-ĐK
letter/Công văn
Decision/Quyết 27/2007/QĐ-
28
định BYT
Joint 06/2007/TTLT-
27 Circular/Thông BVHTT-BYT-
tư liên tịch BNN-BXD
Circular/Thông 01/2007/TT-
25
tư BYT
Decision/Quyết 01/2007/QD-
24
định BYT
Decision/Quyết 30/2006/QĐ-
22
định BYT
Decree/Nghị 89/2006/ND-
21
định CP
Decree/Nghị 79/2006/ND-
20
định CP
Circular/Thông 08/2006/TT-
19
tư BYT
Circular/Thông 06/2006/TT-
18
tư BYT
Decree/Nghị 12/2006/ND-
17
định CP
Circular/Thông 79/2005/TT-
16
tư BVHTT
Official
15 8534/QLD-ĐK
letter/Công văn
Circular/Thông 10/2003/TT-
10
tư BYT
Ordinance/Pháp 39/2001/PL-
6 Advertisement
lệnh UBTVQH10
Decision/Quyết 3121/2001/
5
định QĐ-BYT
Decision/Quyết 2701/2001/ APPLICATION OF “GOOD STORAGE
4
định QĐ-BYT PRACTICES” PRINCIPLE
Decision/Quyết 1570/2000/
2
định QĐ-BYT
Official
1 1790/QLD-ĐK
letter/Công văn
Regulation name (VN) Public date Issuance date Effective date
Quy trình phê duyệt vắc xin covid-19 nhập khẩu cho
29-Jul-2021 29-Jul-2021 29-Jul-2021
nhu cầu cấp bách trong phòng chống dịch bệnh
Cập nhật phụ lục III - Danh mục các chất mà sản
phẩm mỹ phẩm không được chứa ngoại trừ các giới 5-Jul-2021 5-Jul-2021 5-Jul-2021
hạn và điều kiện cho phép
Bảng tổng hợp câu hỏi - trả lời tại Hội nghị phố biến
28-Jun-2021 28-Jun-2021 28-Jun-2021
Nghị định tổ chức, hoạt động dược lâm sàng
Dự thảo hướng dẫn chi tiết luật bảo vệ môi trường 21-Jun-2021 21-Jun-2021 21-Jun-2021
Dự thảo quy trình kiểm định trang thiết bị y tế 8-Feb-21 8-Feb-21 8-Feb-21
Dự thảo Quy định một số nội dung trong đấu thầu
8-Apr-2020 8-Apr-2020 8-Apr-2020
trang thiết bị y tế tại các cơ sở y tế công lập
Cập nhật Danh mục Biệt Dược gốc 7-Apr-2020 7-Apr-2020 7-Apr-2020
Đính chính, điều chỉnh thông tin tại các Quyết định
30-Mar-2020 30-Mar-2020 30-Mar-2020
công bố danh mục thuốc biệt dược gốc
Đính chính, điều chỉnh thông tin tại các Quyết định
30-Mar-2020 30-Mar-2020 30-Mar-2020
công bố danh mục thuốc biệt dược gốc
Đính chính, điều chỉnh thông tin tại các Quyết định
14-Feb-2020 14-Feb-2020 14-Feb-2020
công bố danh mục thuốc biệt dược gốc
Đăng ký, nhập khẩu, sản xuất các thuốc chứa hoạt
23-Jan-2020 22-Jan-2020 22-Jan-2020
chất Galantamin đường tiêm
Đăng ký, nhập khẩu, sản xuất các thuốc chứa hoạt
23-Jan-2020 22-Jan-2020 22-Jan-2020
chất Secnidazol 1000mg
Đăng ký, nhập khẩu, sản xuất các thuốc phối hợp
[Neomycin sulfat 27200 IU + Dexamethason natri
phosphat 8mg]/8ml & các thuốc phối hợp
23-Jan-2020 22-Jan-2020 22-Jan-2020
[Xylometazolin hydroclorid 7,5 mg + Neomycin (dưới
dạng Neomycin sulfat) 52500 IU + Dexamethason
natri phosphat 15mg]/15ml
Đăng ký, nhập khẩu, sản xuất các thuốc chứa phối
23-Jan-2020 22-Jan-2020 22-Jan-2020
hợp [Paracetamol + NSAIDs]
Đăng ký, nhập khẩu, sản xuất các thuốc chứa hoạt
23-Jan-2020 22-Jan-2020 22-Jan-2020
chất Mephenesin
Báo cáo tình hình sản xuất, xuất khẩu, nhập khẩu
thuốc theo quy định tại Điều 47 và khoản 21 điều 91 20-Dec-2019 20-Dec-2019 20-Dec-2019
Nghị định số 54/2017/NĐ-CP
Quy định chi tiết thi hành một số điều của nghị định
số 43/2017/NĐ-CP ngày 14 tháng 4 năm 2017 của 21-Aug-2019 21-Aug-2019 1-Jan-2021
chính phủ về nhãn hàng hóa
Hướng dẫn thủ tục nhập khẩu Trang thiết bị y tế 12-Aug-2019 12-Aug-2019 12-Aug-2019
cập nhật quy định về các chất dùng trong mỹ phẩm 9-Aug-2019 9-Aug-2019 9-Aug-2019
Thực hiện cấp đăng ký lưu hành đối với trang thiết
28-Jun-2019 28-Jun-2019 28-Jun-2019
bị y tế thuộc loại B, C, D.
Triển khai xem xét kê khai lại giá thuốc sản xuất
23-Jun-2019 23-Jun-2019 23-Jun-2019
trong nước tại NĐ 155
Tài liệu thẩm định quy trình sản xuất thuốc thành
5-Jun-2019 5-Jun-2019 5-Jun-2019
phẩm, ứng dụng trong sản xuất và đăng ký thuốc
Quy định về cửa khẩu nhập khẩu vắc xin 23-May-2019 23-May-2019 23-May-2019
Hướng dẫn việc thu hồi và tiêu hủy vắc xin 23-May-2019 23-May-2019 23-May-2019
Quyết định 330/QĐ-QLD năm 2019 về "Chuẩn yêu
cầu dữ liệu đầu ra phần mềm ứng dụng công nghệ
thông tin kết nối liên thông cơ sở phân phối thuốc" 22-May-2019 22-May-2019 22-May-2019
Phiên bản 1.0 do Cục trưởng Cục Quản lý Dược
ban hành
Hướng dẫn cấp, cấp lại Giấy chứng nhận bài thuốc
7-May-2019 7-May-2019 7-May-2019
gia truyền, phương pháp chữa bệnh gia truyền
Danh sách các đơn vị cung cấp phần mềm kết nối
và chuyển dữ liệu thành công vào cơ sở dữ liệu 22-Apr-2019 22-Apr-2019 22-Apr-2019
dược quốc gia
Bảng tổng hợp trả lời câu hỏi tại buổi hội thảo phổ
biến nghị định 155/2018/NĐ-CP, thông tư số 7-Mar-2019 7-Mar-2019 7-Mar-2019
35/2018/TT-BYT thông tư số 36/2018/TT-BYT
Tài liệu hướng dẫn cấp tài khoản liên thông kết nối
với hệ thống "cơ sở dữ liệu quốc gia" cho cơ sở bán 6-Mar-2019 6-Mar-2019 6-Mar-2019
lẻ thuốc (tài liệu dành cho sở y tế)
đăng ký, nhập khẩu đơn hàng các thuốc chứa hoạt
chất Sulfaguanidin; các thuốc chứa hoạt chất
Ephedrin đơn thành phần dùng đường uống và các 24-Jan-2019 24-Jan-2019 24-Jan-2019
thuốc chứa hoạt chất Nitroglycerin dùng đường
uống
đăng ký, nhập khẩu đơn hàng thuốc chứa hoạt chất
24-Jan-2019 24-Jan-2019 24-Jan-2019
paracetamol dạng giải phóng biến đổi
Tài liệu phổ biến nghị định 169 quản lý trang thiết bị
16-Jan-2019 16-Jan-2019 16-Jan-2019
y tế
Hướng dẫn tạm thời việc triển khai kết nối liên thông
28-Dec-2018 28-Dec-2018 28-Dec-2018
dữ liệu liên thông cơ sở bán lẻ thuốc
cập nhật danh mục TTHC thuộc lĩnh vực Trang thiết
22-Oct-2018 22-Oct-2018 22-Oct-2018
bị và Công trình y tế
cập nhật danh mục TTHC thuộc lĩnh vực Mỹ phẩm. 22-Oct-2018 22-Oct-2018 22-Oct-2018
Thực hiện điều chỉnh hiệu lực giấy phép Nhập khẩu
23-Jul-2018 23-Jul-2018 23-Jul-2018
trang thiết bị y tế
Bổ sung phạm vi kinh doanh thuốc phải kiểm soát
16-Jul-2018 16-Jul-2018 16-Jul-2018
đặc biệt
Cập nhật thông tin hướng dẫn sử dụng đối với thuốc
chứa Cefmetazol dùng đường tiêm tĩnh mạch, tiêm 13-Jul-2018 13-Jul-2018 13-Jul-2018
truyền tĩnh mạch
cung cấp thông tin liên quan đến ADR của các thuốc
21-Jun-2018 21-Jun-2018 21-Jun-2018
chứa Chymotrypsin (Alpha-chymotrypsin)
hướng dẫn xây dựng, tổng hợp nhu cầu thuốc đấu
22-May-2018 22-May-2018 22-May-2018
thầu tập trung cấp quốc gia 2018.
Đăng ký, nhập khẩu đơn hàng thuốc chứa hoạt chất
16-Apr-2018 16-Apr-2018 16-Apr-2018
Citicolin dùng đường uống
Thực hiện nhập khẩu đối với trang thiết bị B, C, D 23-Mar-2018 23-Mar-2018 23-Mar-2018
đăng ký, nhập khẩu đơn hàng thuốc chứa hoạt chất
15-Mar-2018 15-Mar-2018 15-Mar-2018
paracetamol dạng giải phóng biến đổi
hướng dẫn cách chuẩn bị nộp hồ sơ đăng ký thuốc 5-Jan-2018 5-Jan-2018 5-Jan-2018
Thống nhất thông tin chỉ định đối với thuốc chứa
Alphachymotrypsin đường dùng uống, ngậm dưới 26-Dec-2017 26-Dec-2017 26-Dec-2017
lưỡi
Triển khai quản lý giá thuốc tại nhà thuốc bệnh viện
1-Dec-2017 1-Dec-2017 1-Dec-2017
theo nghị định 54
Cập nhật thông tin hướng dẫn sử dụng đối với thuốc
13-Nov-2017 13-Nov-2017 13-Nov-2017
chứa Citicolin dùng đường tiêm
Cung cấp thông tin liên quan đến tính an toàn của
thuốc cản quang có chứa gadolinium; thuốc chứa
codein, tramadol; thuốc chứa hyoscine butylbromide 15-Aug-2017 15-Aug-2017 15-Aug-2017
dạng tiêm; thuốc chứa risperidone; thuốc sát trùng
chứa chlorhexidine gluconate
cập nhật thông tin dược lý đối với thuốc chứa kháng
27-Apr-2017 27-Apr-2017 27-Apr-2017
sinh nhóm fluoroquinolon
Cập nhật thông tin dược lý đối với thuốc chứa hoạt
27-Apr-2017 27-Apr-2017 27-Apr-2017
chất hydroxyzin
cung cấp thông tin liên quan đến tính an toàn của
thuốc tránh thai khẩn cấp chứa levonorgestrel,
30-Mar-2017 30-Mar-2017 30-Mar-2017
thuốc kháng vi rút tác động trực tiếp (DAA) điều trị
viêm gan siêu vi C, thuốc chứa warfarin
Công khai giá thuốc trúng thầu trung bình năm 2016 28-Dec-2016 28-Dec-2016 28-Dec-2016
Phối hợp hướng dẫn công tác đấu thầu mua thuốc
20-Dec-2016 20-Dec-2016 20-Dec-2016
của các cơ sở y tế.
miễn kiểm tra nhà nước đối với NLTP, PGTP nhập
15-Dec-2016 15-Dec-2016 15-Dec-2016
khẩu để sản xuất hàng xuất khẩu
QUY ĐỊNH VIỆC THỪA NHẬN KẾT QUẢ PHÂN 15-Nov-2016 15-Nov-2016 1-Jan-2017
LOẠI TRANG THIẾT BỊ Y TẾ
Đăng ký, nhập khẩu đơn hàng thuốc chứa phối hợp
20-Sep-2016 20-Sep-2016 20-Sep-2016
Domperidone và chất ức chế bơm Proton
Đăng ký, nhập khẩu đơn hàng thuốc chứa phối hợp
20-Sep-2016 20-Sep-2016 20-Sep-2016
Trypsin và Bromelain
cập nhật thông tin dược lý đối với thuốc chứa acid
9-Sep-2016 9-Sep-2016 9-Sep-2016
zoledronic
Nhập khẩu nguyên liệu salbutamol làm thuốc 23-Aug-2016 23-Aug-2016 23-Aug-2016
cung cấp thông tin liên quan đến tính an toàn của
thuốc chứa Azithromycin, Clozapin, Mycophenolate 4-Jul-2016 4-Jul-2016 4-Jul-2016
mofetil hoặc Clopidogrel
Danh mục thuốc đấu thầu, thuốc đấu thầu tập trung,
5-May-2016 5-May-2016 1-Jul-2016
thuốc được áp dụng hình thức đàm phán giá
Danh mục thuốc sản xuất trong nước đáp ứng yêu
5-May-2016 5-May-2016 1-Jul-2016
cầu về điều trị, giá thuốc và khả năng cung cấp
cung cấp thông tin liên quan đến ADR của các thuốc
11-Mar-2016 11-Mar-2016 11-Mar-2016
chứa Cefotaxim
Danh mục cập nhật cảnh báo tính đến 23/2/2016 23-Feb-2016 23-Feb-2016 23-Feb-2016
hướng dẫn triển khai dịch vụ công mức độ 4 trong 22-Jan-2016 22-Jan-2016 22-Jan-2016
lĩnh vực đăng ký thuốc
Quy định về hoạt động kinh doanh dược liệu 21-Jan-2016 21-Jan-2016 6-Mar-2016
Cung cấp thông tin liên quan đến tính an toàn của
thuốc điều trị ĐTĐ type 2 nhóm DPP-4, thuốc chứa 14-Dec-2015 14-Dec-2015 6-May-2016
Methotrexate, thuốc NSAID không phải Aspirin
Bảng phân công chuyên viên phòng đăng ký 1-Aug-2015 1-Aug-2015 1-Aug-2015
Hướng dẫn Quốc gia về Cảnh giác Dược 1-Jun-2015 1-Jun-2015 1-Jun-2015
Cung cấp thông tin liên quan đến tính an toàn của
thuốc chứa Ambroxol, Bromhexine, thuốc chứa
18-May-2015 18-May-2015 18-May-2015
Hydroxyzine, thuốc chứa Hydrochloroquine,
Chloroquine, thuốc chứa Topiramate
Cập nhật thông tin dược lý đối với thuốc olmesartan
12-May-2015 12-May-2015 12-May-2015
medoxomil
Cập nhật thông tin dược lý đối với chế phẩm chứa
27-Mar-2015 27-Mar-2015 27-Mar-2015
diacerein
Đình chỉ lưu hành và thu hồi các thuốc chứa hoạt
23-Mar-2015 23-Mar-2015 23-Mar-2015
chất Lysozym
Đình chỉ lưu hành và thu hồi các thuốc chứa hoạt
23-Jan-2015 23-Jan-2015 23-Jan-2015
chất Lysozym
Hướng dẫn ghi nhãn hàng hóa đối với thực phẩm,
phụ gia thực phẩm và chất hỗ trợ chế biến thực 27-Oct-2014 27-Oct-2014 19-Dec-2014
phẩm bao gói sẵn
Danh mục các chất đang còn bảo hộ sáng chế tại
Việt Nam đã gửi thông báo đến Cục quản lý Dược 27-Aug-2014 27-Aug-2014 27-Aug-2014
tính đến ngày 27/8/2014
Đính chính công văn số 11393/QLD-ĐK ngày
04/7/2014 về việc hướng dẫn sử dụng thuốc An 29-Jul-2014 29-Jul-2014 29-Jul-2014
cung ngưu hoàng hoàn
Cấp số đăng ký sản xuất, lưu hành thuốc dược liệu 26-Jun-2014 26-Jun-2014 26-Jun-2014
Cập nhật thông tin dược lý đối với thuốc chứa phối
3-Jun-2014 3-Jun-2014 3-Jun-2014
hợp cyproteron acetat và ethinyl estradiol
Hướng dẫn tạm thời việc gia hạn số đăng ký, thời
hạn nộp hồ sơ đăng ký lại sinh phẩm chẩn đoán 27-May-2014 27-May-2014 27-May-2014
invitro
Danh mục cập nhật cảnh báo tính đến 15/5/2014 15-May-2014 15-May-2014 15-May-2014
Cập nhật thông tin liên quan đến thuốc chứa epoetin
28-Mar-2014 28-Mar-2014 28-Mar-2014
alpha
Đăng ký, lưu hành thuốc chứa hoạt chất cefetamet 28-Mar-2014 28-Mar-2014 28-Mar-2014
Danh mục thuốc thiết yếu tân dược lần VI 26-Dec-2013 26-Dec-2013 10-Feb-2014
Về việc xác định tên khoa học đối với dược liệu Biển
27-Nov-2013 27-Nov-2013 27-Nov-2013
súc của thuốc lưu hành
Hướng dẫn hoạt động thông tin, quảng cáo thuốc 4-Oct-2013 4-Oct-2013
Hướng dẫn tạm thời việc gia hạn số đăng ký và thời
19-Sep-2013 19-Sep-2013 19-Sep-2013
hạn nộp hồ sơ đăng ký lại
Sửa đổi cách ghi chỉ định của thuốc chứa hoạt chất
5-Aug-2013 5-Aug-2013 5-Aug-2013
glucosamin
Đăng ký lưu hành thuốc chứa dẫn chất Terpenic 6-Dec-2012 6-Dec-2012 6-Dec-2012
Đăng ký, lưu hành thuốc chứa hoạt chất
29-Nov-2012 29-Nov-2012 29-Nov-2012
Trimetazidin
Lưu hành thuốc chứa thành phần Calcitonin 5-Oct-2012 5-Oct-2012 5-Oct-2012
Đăng ký thuốc Natri Bicarbonate dùng đường uống 13-Sep-2012 13-Sep-2012 13-Sep-2012
Quy định nguyên tắc, tiêu chuẩn “Thực hành tốt sản
xuất bao bì dược phẩm” và hướng dẫn việc triển 31-Aug-2012 31-Aug-2012 15-Oct-2012
khai, áp dụng
Quyết định 2962/QĐ-BYT năm 2012 về Quy định
tạm thời tài liệu cần cung cấp để công bố danh mục
thuốc biệt dược gốc, thuốc tương đương điều trị với
22-Aug-2012 22-Aug-2012 22-Aug-2012
thuốc biệt dược gốc, thuốc có tài liệu chứng minh
tương đương sinh học do Bộ trưởng Bộ Y tế ban
hành
Danh sách các nước tham gia EMA, ICH, PICS 18-Jun-2012 18-Jun-2012 18-Jun-2012
Kiểm định sinh phẩm chẩn đoán HIV 5-Apr-2012 5-Apr-2012 5-Apr-2012
Hướng dẫn cách ghi chỉ định, liều lượng, cách dùng
3-Apr-2012 3-Apr-2012 3-Apr-2012
của thuốc chứa Arginin
Hướng dẫn cách ghi tác dụng dược lý, chỉ định và
3-Apr-2012 3-Apr-2012 3-Apr-2012
liều dùng của thuốc chứa Thymomodulin
Cung cấp tài liệu lâm sàng thuốc Duxil (Almitrine-
3-Apr-2012 3-Apr-2012 3-Apr-2012
Raubasine)
Hướng dẫn về thử thuốc trên lâm sàng 2-Feb-2012 2-Feb-2012 20-Mar-2012
Hướng dẫn đấu thầu mua thuốc trong cơ sở y tế 19-Jan-2012 19-Jan-2012 1-Jun-2012
Bổ sung chống chỉ định đối với thuốc chứa phối hợp
21-Jul-2011 21-Jul-2011 21-Jul-2011
pseudoephedrin và triprolidin
Hướng dẫn ghi chỉ định điều trị, chống chỉ định và
16-Jun-2010 16-Jun-2010 16-Jun-2010
liều dùng glucosamin
Hướng dẫn các hoạt động liên quan đến thuốc gây
29-Apr-2010 29-Apr-2010 13-Jun-2010
nghiện
Hướng dẫn việc quản lý chất lượng thuốc 28-Apr-2010 28-Apr-2010 1-Jul-2010
Ban hành Danh mục thuốc không kê đơn 1-Jul-2009 1-Jul-2009 15-Aug-2009
Hướng dẫn cấp phép, đăng ký, thực hiện quảng cáo
trên báo chí, mạng thông tin máy tính, xuất bản 18-Dec-2008 18-Dec-2008 16-Jan-2009
phẩm và công tác thanh tra, kiểm tra, xử lý vi phạm
Phản ứng có hại của các thuốc thuộc nhóm Statin 4-Dec-2008 4-Dec-2008 4-Dec-2008
Hướng dẫn thủ tục cấp giấy phép thực hiện quảng
28-Feb-2007 28-Feb-2007 23-Apr-2007
cáo một cửa liên thông
"Quy định về thử thuốc trên lâm sàng" 11-Jan-2007 11-Jan-2007 18-Feb-2007
Hướng dẫn nhập khẩu vắc xin, sinh phẩm y tế; hoá
chất, chế phẩm diệt côn trùng, diệt khuẩn dùng 13-Jun-2006 13-Jun-2006 9-Jul-2006
trong lĩnh vực gia dụng và y tế và trang thiết bị y tế
Hướng dẫn sản xuất gia công thuốc 28-May-2004 28-May-2004 26-Jun-2004
Valid
Ministry of
Health/Bộ Y tế
Valid until:
December 31,
Government/ 2022
Chính phủ
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
General
Department of
Customs/Tổng
cục hải quan
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
General
Department of
Customs/Tổng
cục hải quan
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
General
Department of
Valid
Customs/Tổng
cục hải quan
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
General Valid
Department of
Customs/Tổng
cục hải quan
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid until:
December 31,
2022
Ministry of
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
General
Department of
Valid
Customs/Tổng
cục hải quan
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
General Valid
Department of
Customs/Tổng
cục hải quan
Valid
Ministry of
Health/Bộ Y tế
General Valid
Department of
Customs/Tổng
cục hải quan
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Unknown
Government/
Chính phủ
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
General Valid
Department of
Customs/Tổng
cục hải quan
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Government/
Chính phủ
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Unknown
Government/
Chính phủ
Valid
Ministry of
Health/Bộ Y tế
Valid
ASEAN
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid September
01, 2021
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
General
Department of
Customs/Tổng
cục hải quan
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Government/
Chính phủ
Valid
Ministry of
Health/Bộ Y tế
Ministry of
National
Unknown
Resources and
Environment
Ministry of
Invalid
Health/Bộ Y tế
Valid
Government/
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid (from
Finance/Bộ Tài
1.August.21)
chính
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Valid
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Government/
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Government/
Valid
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
ASEAN
Valid
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
General
Department of
Customs/Tổng Valid
cục hải quan
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài Valid
chính
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Valid
Government/
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
General Valid
Department of
Customs/Tổng
cục hải quan
Unknown
Government/
Chính phủ
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Finance/Bộ Tài
chính
Ministry of
Valid
Health/Bộ Y tế
Government/ Unknown
Chính phủ
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Government/ Unknown
Chính phủ
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Government/ Unknown
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/ Unknown
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Finance/Bộ Tài
chính
Unknown
Government/
Chính phủ
Unknown
Government/
Chính phủ
Government/ Unknown
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of Unknown
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Invalid from May
28, 2021
Ministry of
Health/Bộ Y tế
General
Department of Valid
Customs/Tổng
cục hải quan
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài Valid
chính
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Unknown
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Valid
Ministry of
Valid
Health/Bộ Y tế
General
Department of
Customs/Tổng
cục hải quan Valid
Ministry of
Valid
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Valid
Chính phủ
Ministry of
Science and
Technology/Bộ
KH&CN Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Invalid
General
Department of
Customs/Tổng Valid
cục hải quan
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Justice/Bộ Tư Unknown
pháp
Ministry of
Health/Bộ Y tế Valid
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Valid
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of Invalid
Science and
Technology/Bộ
KH&CN
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
ASEAN
Unknown
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Agriculture and
Rural
Development/Bộ Valid
Nông nghiệp và
phát triển nông
thôn
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of Valid
Science and
Technology/Bộ
KH&CN
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Valid
Government/
Valid
Chính phủ
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Prime
Minister/Thủ Valid
tướng chính phủ
Ministry of
Finance/Bộ Tài Valid
chính
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế Valid
Ministry of
Health/Bộ Y tế Valid
Ministry of
Agriculture and
Rural
Development/Bộ Valid
Nông nghiệp và
phát triển nông
thôn
Ministry of
Industry and
Valid
Trade/Bộ Công
thương
Ministry of
Health/Bộ Y tế
Valid
Government/
Valid
Chính phủ
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Valid
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Valid
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Industry and
Valid
Trade/Bộ Công
thương
Ministry of
Unknown
Health/Bộ Y tế
General
Department of
Customs/Tổng Unknown
cục hải quan
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Invalid partially
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Unknown
Ministry of
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Invalid partially
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Unknown
Health/Bộ Y tế
Vietnam Social
Security/Bảo
hiểm xã hội Việt Valid
Nam
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài Valid
chính
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Invalid partially
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Valid
Chính phủ
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Invalid
Ministry of
Finance/Bộ Tài Valid
chính
Ministry of
Finance/Bộ Tài Valid
chính
Ministry of
Finance/Bộ Tài Valid
chính
Government/
Valid
Chính phủ
Ministry of
Health/Bộ Y tế Valid
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Invalid partially
Chính phủ
Government/
Invalid partially
Chính phủ
Government/
Invalid partially
Chính phủ
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Agriculture and
Rural
Development/Bộ Valid
Nông nghiệp và
phát triển nông
thôn
Ministry of
Agriculture and
Rural
Development/Bộ Valid
Nông nghiệp và
phát triển nông
thôn
Government/
Valid
Chính phủ
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
National
Assembly/Quốc Valid
hội
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid partially
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Government/
Valid
Chính phủ
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Unknown
Health/Bộ Y tế
ASEAN
Unknown
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế
Valid
Ministry of
Health/Bộ Y tế Invalid partially
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Ministry of Invalid
Finance/Bộ Tài
chính
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid partially
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid partially
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài Valid
chính
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
ASEAN
Unknown
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Invalid
Ministry of
Health/Bộ Y tế
Ministry of Invalid
Finance/Bộ Tài
chính
Ministry of
Health/Bộ Y tế Invalid partially
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Ministry of
Agriculture and
Rural
Development/Bộ
Nông nghiệp và Invalid
phát triển nông
thôn
Ministry of
Industry and
Trade/Bộ Công
thương
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Invalid
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Valid
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Ministry of Invalid
Finance/Bộ Tài
chính
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài Valid
chính
Government/
Valid
Chính phủ
Ministry of
Valid
Health/Bộ Y tế
National
Assembly/Quốc Valid
hội
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế Invalid
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Culture, Sports
and Tourism/Bộ Valid
Văn hóa, Thể
thao và Du lịch
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế Invalid
Ministry of
Health/Bộ Y tế Invalid
Government/
Valid
Chính phủ
Government/ Invalid
Chính phủ
Ministry of
Health/Bộ Y tế
Ministry of Invalid
Finance/Bộ Tài
chính
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Construction/Bộ Invalid
xây dựng
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Prime
Minister/Thủ Invalid
tướng chính phủ
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Industry and
Invalid
Trade/Bộ Công
thương
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài Invalid
chính
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Government/
Invalid
Chính phủ
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Government/
Invalid
Chính phủ
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
National
Assembly/Quốc Valid
hội
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Ministry of Invalid
Finance/Bộ Tài
chính
Ministry of
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài
chính Invalid
Ministry of
Industry and
Trade/Bộ Công
thương
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế
Invalid partially
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Health/Bộ Y tế
Invalid
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid partially
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid partially
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Health/Bộ Y tế
Invalid partially
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Information and
Communications
/Bộ Thông tin và
Truyền thông
Invalid
Ministry of
Culture, Sports
and Tourism/Bộ
Văn hóa, Thể
thao và Du lịch
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài Invalid
chính
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Prime
Minister/Thủ Invalid
tướng chính phủ
Ministry of
Health/Bộ Y tế
Ministry of
Finance/Bộ Tài
chính Invalid
Ministry of
Industry and
Trade/Bộ Công
thương
Ministry of
Health/Bộ Y tế
Ministry of Invalid
Finance/Bộ Tài
chính
Ministry of
Trade/Bộ Invalid
Thương mại
Ministry of
Unknown
Health/Bộ Y tế
Ministry of
Ministry of
Health/Bộ Y tế Invalid
Health/Bộ Y tế
Ministry of
Culture And
Information/Bộ
Văn hóa - thông
tin
Ministry of
Construction/Bộ Invalid
xây dựng
Ministry of
Agriculture and
Rural
Development/Bộ
Nông nghiệp
Ministry of và
phát triển nông Invalid
Health/Bộ Y tế
thôn
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Valid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Government/
Invalid
Chính phủ
Government/
Invalid
Chính phủ
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Government/
Invalid
Chính phủ
Ministry of
Culture And
Information/Bộ Invalid
Văn hóa - thông
tin
Ministry of
Unknown
Health/Bộ Y tế
National
Assembly/Quốc Invalid
hội
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Culture And
Information/Bộ Invalid
Văn hóa - thông
tin
Government/
Valid
Chính phủ
Government/
Invalid
Chính phủ
National
Assembly/Quốc Invalid
hội
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Invalid
Health/Bộ Y tế
Ministry of
Unknown
Health/Bộ Y tế
Summary
The Resolution prescribes a number of special mechanisms and policies for grant of certificates of registration for m
authorization of COVID-19 treatment drugs and vaccines manufactured in Vietnam as follows:
- With respect to domestically-manufactured COVID-19 treatment drugs and vaccines that are undergoing clinical tri
the phase-3 mid-term evaluation of these drugs’ safety and therapeutic efficacy or these vaccines’ protective efficac
immunogenicity data have been obtained, they may be used for considering the conditional certification of registratio
authorization after:
Currently,
+ Consultationtherewith is athe
phenomenon
National Ethicsof taking advantage
Committee of the Covid-19
in Biomedical Research epidemic situation
for drugs to sell drugs
and vaccines to treat Covid
undergoing clinic
origin.
+ Consultation with the Advisory Council on issuance of certificates of marketing authorization of drugs and medicin
In order drugs
specific to strengthen
or vaccinesthe management
with referenceoftothe thepharmaceutical sector, ensure the
guidance or recommendations of safety
the Worldof users,
Healthand serve the prev
Organization (WH
of the Covid-19
- Further monitoringepidemic, the Drug
of safety, Administration
efficacy and management of Vietnam requires:number of doses and scope of administration
of recipients,
1. The establishments
vaccines are required after strictly implement
certificates of the use of materials
registration importauthorization
for marketing licensed for the right purposes
of these drugs andaccording
vaccines are to the
gr
agreeing
In addition totoimport
the Molnupiravir,
aforesaid Favipiravir,
regulations, any Baricitinib,
other 2-Deoxy-D-Glucose
regulations related to of the Drug
registration for Administration
marketing of Vietnam.
authorization of dru
Some key points in the letter.
2.
for Establishments
prevention the anduseshall report
control and update
of Covid-19 withinmust
disease 24 hours sinceto there
law.istemplate.
a change (increase, decrease) in the quanti
1. Announce purpose, product features inbethe
subject
notification
medicinal ingredients (Molnupiravir, Favipiravir, Baricitinib, 2-Deoxy-D- Glucose) on the website dichvucong.dav.gov
- According to regulations, changes in use purposes after the notification of cosmetic products are subject to new no
(Appendix No. 05 of Circular No. 06/2011/TT-BYT).
- The advertising content must be consistent with the cosmetic product notification template; documents proving the
effectiveness of cosmetics and compliance with the guidelines on cosmetic product feature notification of the Interna
(if any).
a) Because the classification of goods (applying HS codes) must be based on Clause 16, Article 4 and Clause 1, Art
Therefore, the proposal of the Association "Businesses only need to announce the main uses and features of the pr
Customs Law. The description of MDs in the list of MDs subject to specialized management by the Ministry of Health
notification the features of cosmetics is not appropriate.
under Circular 14/2018/TT-BYT is incomplete with information on composition, physical and chemical properties, fea
2. About how to write the percentage on the notification template.
other attributes of the goods. According to the List of exported and imported goods of Vietnam, there is not enough b
When representing the decimal point of the measurand value, a comma (,) must be used, not a period (.)".
determine the code.
“Specify the percentage of ingredients with regulations on concentration and concentration limits in the Annexes of t
The Ministry of Finance proposed the Ministry of Health to consider removing Clause 2, Article 2 of Circular 14 beca
Cosmetic Agreement. Between the units and decimal places is marked with a comma (“,”).
suitable: "List of MD has determined the product code issued together with this circular as the basis for organization
Therefore, the Association's proposal to Drug Administration of Vietnam to "consider flexibly accepting the full period
to make customs declarations when importing"
commas for decimals as at present in accordance with the bilingual spirit of the notification template" is not appropri
b) About the list under the specialized management of the Ministry of Health.
3. CFS the
Facing requirements insituation disclosure procedures.
Some itemscomplicated
have been applied with of the Covid-19 epidemic
inappropriate in the world
codes, request the MOH as well as in Vietnam,
to correct the name, there are complicated
description, and cod
Pursuanttotostrengthening
addition Article 36 of the Law onand
research Foreign TradeofManagement,
production Covid-19 Article many
vaccines, 10 of Decree
countries 69/2018/ND-CP;
around the world Because
have beg the
remarkable items:
cosmetic on
research product
new notification
drugs to have template
more already contains
effective solutions the
in contents
treating of the certificate
patients with of free sale, so Clause 1, Artic
Covid-19.
Sea salt solution for nasal hygiene, ear spray, artificial tears, gel for open wounds, kidney dialysis fluid, vaginal Lubr
29/2020/TT-BYT has stipulated
Currently, drugs containing active allowing enterprises
ingredients to submit
Molnupiravir, the notification
Favipiravir, template
Remdesivir, of cosmetic
Sotrovimab, products2-Deoxy
Baricitinib, that hav
marketing in an ASEAN country as an alternative to CFS. However, the product
DG), monoclonal antibody duos: Casirivimab and Imdevimab, Bamlaivimab and Etesevimab,... are being developed notification template must be of cos
circulating
development
Currently, in
drugsthe country
in many of manufacture
countries
containing active around or export
the world.
ingredients to comply with
AccordingRemdesivir,
Molnupiravir, the provisions
to collectedSotrovimab, of the Foreign
information, Baricitinib, Trade
drugs containing
2-Deoxy Law and
theDactive Decre
Glucoseing
4. Regarding
Molnupiravir,antibody
monoclonal the 1-door
Favipiravirduos: publication
andCasirivimab
some of theandsystem.
above monoclonal
Imdevimab, antibodiesand
Bamlaivimab areEtesevimab,...
promising in the aretreatment of Covid-19.
being developed, rese
Noting
In ordersystem
countries toaround errors,
prepare the DAV
forworld. will coordinate
the submission
According of with relevant
to marketing
collected units to drugs
authorization
information, solve and provide
application and the
containing timely
shorten
activesupport
the for businesses
review
ingredient time, the DrugaA
Molnupiravir
Vietnam
above recommends
monoclonal the units
antibodies areasvery
follows:
promising in the treatment of Covid-19.
1. Expeditiously
The completeofthe
Drug Administration preparation
Vietnam and submission
recommends the units:of application for registration of circulation of drugs to pre
Covid-19
In order toaccording
Strengthen research,to
promptly regulations
update
prevent the on registration
theproduction,
trend of research ofand
sale and drug
use circulation.
production of drugs
of counterfeit to treat
drugs, drugsCovid-19
of unknown in the world,
origin andaccess
poor quato
2. Review
supply, and
import report
to on
Vietnam difficulties
to actively and problems
research and related
produce to the
drugssubmission
to treat of application
Covid-19
adequate supply of drugs, safety, quality and effectiveness for patients, During the anti-epidemic period, the Drug Afocus for
on registration
raw materials of circulatio
Molnupira
according
monoclonal toantibodies,...
regulations (if any) and propose solutions to remove difficulties and obstacles to ensure timely supply o
Vietnam recommends:
and control Covid-19.
1. The Departments of Health of the provinces and centrally-run cities regularly update the situation of pharmaceutic
activities in their localities, report to and advise the People's Committees of the provinces and cities.
2. National Institute of Drug Quality Control, Ho Chi Minh City Institute of Drug Quality Control have strengthened sa
control of drugs circulating in the market, focusing on sampling for drugs on the List of drugs to prevent and control t
epidemic.
The main points stated in the letter:
1. For customs clearance docuents: Clause 2, Article 92, Decree 54, MA is not required. Official Letter 1968/QLD-D
customs on instructions for searching MA information. In case the published information is missing, modified or diffe
customs to ask the enterprise to provide the original or a valid copy of the MA or Decision for comparison.
2. Maintain validity registration number as Circular 32, Circular 29. Medicines are maintained to ensure timely supply
period to meet practical needs, especially during the Covid-19 period. From January 1, 2021, DAV implemented an
maintenance settlement system and issued Official Letter 777/QLD-DK dated February 3, 21 send to Customs and b
drugs
In ordermaintained
to promptly before 1/1/21.Decisions
implement Request Customs to ask enterprises
No. 412/QD-BYT, Decision No. to present the original
3597/QD-BYT andor a valid copy
Decision for comp
No. 318/QD-Q
3. Correction, change and addition of MA information. In case the drug has been granted
issuance of inter-connected accounts connecting wholesale establishments nationwide,Drug Administration recomm an MA but there is incorrec
the MA decision papers due to negligence in the preparation of the application form of the
1. The Departments of Health of the provinces and centrally-run cities shall urgently issue inter-connected accounts enterprises or the drafting
DAV. DAV
wholesalers. has official letter to correct and amend information.
4. Drug
2. Importer's information
wholesalers on MA:
urgently Point b,Decision
implement Clause 1,No. Article 44 of the to
318/QD-QLD Pharmacy Law, establishments
ensure compliance that have been g
with regulations.
certificate
3. Software ofproviders
eligibility for
make pharmaceutical
inter-connectionbusiness within the
as prescribed in scope
Articleof17importation,
of Decisionare No.entitled to import
412/QD-BYT anddrugs accor
instruction
Faced
the withofthe
provisions
Appendix situation
Article
issued 60 ofofPharmacy
togetherthewith
Covid-19
Law.epidemic
Official Therefore,
Letter No.in Vietnam as well as
it is inappropriate
24026/QLD-TTr toinspecify
dated the
28 world, which2018
information
December tends
aboutto importers
be complicated,
on the
disruption and disruption of global supply to ensure the demand for anti-epidemic drugs. Covid-19 in particular and d
rights of enterprises.
Vietnam, the Drug Administration of Vietnam recommends:
1. Leaders of the Units proactively review the drug inventory at the facility and the supply capacity of the suppliers to
solutions
The Ministryto ensure
of Healththecontinues
supply of to drugs at the
update andunit, notthe
notify to cause shortage of
list of biological drugs. serving the
products/medical medical for
equipment examination
in vitro dia
the people, especially Covid-19 patients.
SARS-CoV-2 testing that have been granted circulation registration numbers; for Departments of Health and Hospita
2. Units shall
Institutes report specifically
to actively contact anddrugs have with difficulties in
a procurement supply
plan (if any)
to serve theand
needs propose demand
of epidemic to the Drug
prevention andAdministrat
control un
drugs for the prevention and treatment of Covid-19
the Government and the guidance of the Ministry of Health. before August 10, 2021.
In order for the health department to be proactive in strengthening the inspection, examination and handling of viola
prevention and control of the COVID-19 epidemic.
The Ministry
Proposing of Health shall
manufacturers temporarily
and importersguide the payment
of biological of medical examination
products/medical and
equipment for treatment expenses
SARS-CoV-2 testing toand for h
proacti
insurance cards during the period of medical isolation. Center and some other cases during the epidemic due to
have a plan to stabilize, reserve raw materials, increase production, and ensure import quantity and quality to meet CO
COVID-19 epidemic prevention and control.
Received a complaint from the border-gate customs office requesting to submit the medical equipment import licens
equipment circulation permit in paper form and not accepting the electronic license issued on the public service syst
of Health has the following comments:
- According to the provisions of Article 58, Decree No. 36/2016/ND-CP stipulating the procedures for "Announcemen
medical equipment application", "Registration of circulation of medical equipment" and "Application for a license to im
equipment” is done in the form of an online license on the online public service system.
-- From September
Pursuant to Article1,14,2021 to theNo.
Decree end45/2020/ND-CP
of September 30, 2021,
dated to 8,
April pilot
20205 administrative procedures
of the Government on theofimplementation
the Ministry of oH
(1) Grantinginimport
procedures license for
the electronic medical equipment.
environment stipulates: “Results of administrative procedures settlement in the electron
(2) Granting
electronic importoflicense
version for medical
the competent equipment
authority containing
has the narcotics
same legal value as andthe
precursors.
result of administrative procedures in w
(3) Issuing
Ministry licenses
of Health didtonot
import
issue raw materials
a paper for the
license for production of medical equipment
the three administrative procedurescontaining narcotics
mentioned above.and precurs
(4)
TheIssuing
Ministrylicenses
of Health to export medical
respectfully equipment
requests containing
the Customs narcotic substances
Department to guide theand precursors,
Custom units toraw materials
accept for thu
and look
medical
the threeequipment containing
administrative proceduresnarcotic substances
mentioned aboveandinprecursors.
the section "Kết quả dịch vụ công" on the web portal on ma
(5) New issuance
equipment of free-sale
of the Ministry registration
of Health at the numbers for medical equipment with
address https://dmec.moh.gov.vn corresponding
when carrying outnational
customstechnical
clearanceregu
pr
-This
From
border October 1,
gate. includes:
decision 2021, all businesses, units and organizations will officially carry out the above 5 administrative pro
National Single
1. Guidelines forWindow.
taking care of people infected with COVID-19 at home.
2. Nutrition guidelines for people infected with COVID-19 at home.
Groups of medicine in the List include:
a) Antipyretic, analgesic drugs;
b) Medicine for balancing electrolytes;
c) Medicine for boosting health and resistance;
d) Throat
This disinfectant;
Decision includes 05 new administrative procedures issued in the field of pharmaceuticals under the managem
đ) Antiviral drugs; in Circular No. 11/2021/TT-BYT dated August 19, 2021 of the Minister of Health on guidelines for
Ministry of Health
e) Corticosteroid
Authorization anti-flammatory
registration of Covid-19medicine;
vaccine in case of emergency.
g) Anticoagulant.
Promulgated together with this Decision are the interim guidelines for prevention and treatment of COVID-19 in preg
newborns.
The General Department of Customs has issued a number of documents directing the Customs Departments of pro
implement a number of solutions as follows:
- Acceptance of COA of drugs and medicinal ingredients with electronic signatures.
- Allow enterprises to bring shipments with special preservation requirements (such as drugs, vaccines, biological pr
require a storage
Distribution temperature
of Covid-19 ofSpikevax
vaccine 2°C-8°C)(covid-19
for physical inspection
vaccine at storage
Moderna) location asaid
US government thetorequest of the
units and enterprise
localities
- Inspection for imported shipments with customs declarations registered from August 1, 2021: yellow lane and red l
This process aims to uniformly stipulate the implementation order and responsibilities of relevant individuals in revie
application for approval of imported Covid-19 vaccines for urgent needs of epidemic prevention and control.
Decision including:
1. List of 66 imported drugs granted Marketing Authorization valid for 5 years
2. List of 17 imported drugs granted Marketing Authorization valid for 03 years
This Decision issues guidelines on the receipt, transport, storage and use of COVID-19 vaccines in the National CO
Campaign in the Appendix attached to the Decision.
- In order to strictly comply with the provisions of the law on the management of chemicals and insecticidal and germ
for household and medical use, Health Environment Management Agency shall send the General Department of Cu
with this letter the List of insecticidal and germicidal preparations containing active ingredients banned for use in the
medical fields that have been granted circulation registration numbers
- Request the General Department to direct to stop the import of preparations and active ingredients for the producti
in the above list from August 20, 2021
This Circular provides for emergency marketing authorization of COVID-19 vaccines, specifically:
1. Applications and procedures for vaccine marketing authorization issuance, renewal and amendment.
2. Requirements for clinical data in applications to ensure vaccine safety and effectiveness.
3. Exemption from one or more than one clinical trial phase and vaccines required to undergo phase 4 clinical trial in
The national centralized drug procurement center would like to send to members the Decision on promulgating the s
negotiating the prices of brand-name drugs.
On the basis of the issued set of criteria, members are requested to actively coordinate with the Center to carry out
negotiation according to regulations.
The Traditional Medicine Administration request that establishments access the online system https://ydct-dichvucon
submit application for registration of circulation of traditional medicines and herbal ingredients on the online system.
The General Department of Customs has issued a number of documents directing the Customs Departments of pro
implement a number of solutions as follows:
- Acceptance of COA of drugs and medicinal ingredients with electronic signatures.
- Allow enterprises to bring shipments with special preservation requirements (such as drugs, vaccines, biological pr
require a storage temperature of 2°C-8°C) for physical inspection at storage location as the request of the enterprise
- Inspection for imported shipments with customs declarations registered from August 1, 2021: yellow lane and red l
* The announcement includes: 03 annexes:
- Annex 1: List of manufacturers meet GMP: 115 manufacturers
- Annex 2: List of manufacturers are revised information compare to previous lists: 74 manufacturers
- Annex 3: List of manufacturers need supplementation, explanation: 111 manufacturers
- Submit dossiers and administrative procedures through the online public service system of the Drug Administration
https://dichvucong.dav.gov.vn.
- For administrative procedures that need to be submitted in paper form, it is recommended that the units do it throu
service.
-- The return
For the of administrative
yellow procedure
lane declaration: results
check and and replies
compare from DAV
the customs will be done
declaration by post
contents withorthe
viacustoms
Fax, Email.
dossier acc
regulations and instructions No. 6068/TCHQ-GSQL, in case the dossier is not suitable or there is doubt about its au
change the red lane to check.
- For the red lane: check and compare the actual goods with the information on the customs declaration and dossier
time request
The MoH the customs
requests declarant
People’s to present
Committee the original:
of provinces LOA, MA,
and centrally runCOA
cities to:
- Instruct local Health Departments, healthcare facilities and pharmaceutical enterprises to promptly develop and
reserve plan to ensure the availability and adequacy of drugs and strictly comply with the State regulations on drug p
The local Health Departments cooperates with relevant units to strengthen inspection and strictly handle establishm
of violating
Prioritize aiddrug price management
shipments or COVID-19
that are cleared within theprevention measures.
day. Strictly handle cadres and civil servants with troublesome att
-customs
Enable pharmaceutical
clearance time production and business establishments to fully and effectively update and apply COVID
and control measures in accordance with the Government’s directions.
This process aims to unify the receipt, appraisal and settlement of dossiers of change and supplementation of MA o
medicinal ingredients (including chemical drugs, herbal drugs, vaccines, biologicals products, radiopharmaceuticals,
ingredients), domestically produced or imported during the validity period of the circulation registration certificate.
The Drug Administration of Vietnam has sent an official dispatch to:
- Departments of Health of provinces and centrally run cities
- Establishments that manufacture and import drugs
Directing pharmaceutical business establishments in the area not to take advantage of the Covid-19 epidemic situat
hoard goods and push up prices of drugs and medicinal ingredients.
Strictly implementing the direction of DAV on ensuring the supply of drugs for the prevention and treatment of covid-
It is necessary to strictly report the quantity of drugs and ingredients for anti-epidemic medicine on the Covid-19 dru
reporting system (https://duocquocgia.com.vn).
The Ministry of Health continues to update and notify the list of biological products/medical equipment for in vitro dia
SARS-CoV-2 testing for the Department of Health and Hospitals, Research Institutes actively contact, have a procur
serve the needs of epidemic prevention and control under the direction of the Government and the guidance of the M
The “Safety criteria for COVID-19 immunization facilities” apply to all facilities providing COVID-19 immunization in o
immunization safety in fixed and mobile immunization facilities
In order to facilitate the settlement of customs procedures for enterprises, for imported goods with special preservati
physical inspection cannot be carried out at the inspection sites of the customs authority
- Accordingly, in Section 6 Decision 3416/QD-BYT dated July 14, 2021, other therapeutic measures, a number of ne
been included in the guidelines: Enoxaparin-containing drugs, Tocilizumab-containing drugs and Regen-Cov2 drugs
monoclonal antibodies including casirivimab 600mg and Enoxaparin). Imdevimab 600mg).
- In order to ensure the adequate supply of drugs and timely serve the needs of disease prevention and control, DAV
that drug manufacturers and importers continue to increase the supply of the above-mentioned drugs, and actively c
medical examination and treatment establishments to promptly grasp the demand for drugs to supply to medical exa
treatment establishments.
To promulgate together with this Decision the list of circulation numbers of medical equipment other than in vitro dia
equipment issued in Vietnam in the 14/2021 period.
Promulgating together with this Decision the list of circulation numbers of in vitro diagnostic medical equipment issue
the 13/2021 issuance.
Conditional approval of the Covid-19 vaccine Janssen.
Name of manufacturer - Country of manufacture:
a) Janssen Pharmaceutica NV - Belgium.
b) Janssen Biologics B.V - The Netherlands.
c) Other facilities producing Covid-19 Vaccine Janssen may be changed based on the vaccine supply capacity at the
importing establishment submits the application for a vaccine import license as prescribed in Clause 1 of this Article.
54/2017/ND-CP.
Issuing together with this Decision "Guidelines for the diagnosis and treatment of COVID-19 caused by a new strain
(SARS-CoV-2)" to replace "Guidelines for the diagnosis and treatment of COVID-19 caused by a new strain of Coro
CoV-2)” issued together with Decision No. 2008/QD-BYT dated April 26, 2021.
Issuing together with this Decision a list of 02 medical equipment for in vitro diagnostics for SARS-CoV-2 testing with
numbers for COVID-19 prevention and control. The registration number is valid for 12 months from the date of issue
The Ministry of Health continues to update and notify the list of biological products/medical equipment for in vitro dia
SARS-CoV-2 testing for the Department of Health and Hospitals, Research Institutes actively contact, have a procur
serve the needs of epidemic prevention and control under the direction of the Government and the guidance of the M
Distribution of COVID-19 vaccine BNT162b2 of Pfizer (Comirnaty) received by the National Expanded Immunization
and localities
There is a document to introduce T&T Group to the Direct Investment Fund of the Russian Federation (RDIF) to neg
purchase 40 (forty) million doses of Sputnik V vaccine from the Russian Federation with legal funds provided by T&T
mobilized (without using funds from the state budget and the Vietnam Covid-19 Vaccine Fund).
Implement import licensing, inspection and quality control of vaccines, organize free injection of all 40 (forty) million
above-mentioned vaccines according to regulations.
The Drug Administration of Vietnam (DAV) issued Official Letter No. 8026/QLD-KD on July 10 to request Health Dep
provinces and centrally run cities, hospitals, healthcare facilities and pharmaceutical businesses to promptly develop
COVID-19 drug reserve plans to ensure the availability and adequacy of the drugs as well as strictly comply with the
on drug price management.
Units with 2-8°C or deep cold storage need to check their capacity, rearrange, and reserve as much capacity as pos
COVID-19 vaccine when requested by the MoH.
Pharmaceutical businesses are asked to consider reducing unnecessary costs in case price of input materials of dru
drugs increases to stabilize drug prices during the COVID-19 pandemic. In case of rare drugs in supply, the DAV wil
quick issuing registration certificates and import permits to promptly supply the drugs to medical facilities.
- In the first 6 months of 2021, DAV has focused on completing and settling over 9,000 applications out of a total of o
applications for temporary extension registration certificate of circulation.
- DAV is continuing to strengthen the processing of applications for extension dossier that expire from July to Decem
have issued 2,376 number of dispatches announcing appraisal results.
- In order to ensure the supply of drugs on the market, DAV requests that the registration establishments receive DL
the application for extension, urgently complete and submit additional documents to DAV.
issued together with this Decision Guidelines for diagnosis and treatment of myocarditis after vaccination against CO
The Ministry of Health continues to update and notify the list of biological products/medical equipment for in vitro dia
SARS-CoV-2 testing for the Department of Health and Hospitals, Research Institutes actively contact, have a procur
serve the needs of epidemic prevention and control under the direction of the Government and the guidance of the M
This process is to unify the receipt, appraisal and submission to Council of granting MA for drug and medicinal ingre
processing of dossiers after the council meeting.
This process is to unify the receipt, appraisal and submission to Council of granting MA for drug and medicinal ingre
processing of dossiers after the council meeting.
- Substances banned from use in the production and trading of health foods include substances in the following lists
- Appendix V "List of drugs and medicinal ingredients banned from import and export" promulgated together with De
CP dated May 8, 2017;
- Lists I, II, III, IVA list of narcotic substances and precursors promulgated together with Decree 73/2018/ND-CP date
- Appendix I "List of addictive drugs" promulgated together with Circular No. 20/2017/TT-BYT dated May 10, 2017;
- List of toxic drugs and toxic medicinal ingredients promulgated together with Circular 06/2017/TT-BYT dated May 3
- Appendices I, II, III of the list of toxic medicinal herbs promulgated together with Circular 42/2017/TT-BYT dated No
- The list of substances is included in the Appendix issued with Circular 10/2021/TT-BYT, for example: Aildenafil, tad
Conditional approval of Spikevax vaccine (Also known as: Covid-19 Vaccine Moderna).
Name of manufacturer - Country of manufacture:
a) Rovi Pharma Industrial Services, S.A - Spain.
b) Recipharm Monts - France.
c) Other Spikevax vaccine manufacturers may be changed based on their vaccine supply capacity at the time the im
establishment submits the application for a license to import vaccines as prescribed in Article 67 of the Decree. 54/2
Distributing the 6th stage of COVID-19 Vaccine (Vero Cell), Inactivated (Also known as SARSCoV-2 Vaccine (Vero
aided by the Chinese Government to units and localities
List of pharmaceutical management agencies of countries that is membership PIC/s and ICH updated up to June 20
- Roadmap for recycling packaging: based on revenue and volume of packaging, from January 1, 2023.
- Organizations and individuals that manufacture and import products and packages with recyclable value must recy
the compulsory recycling rates and specifications, except for products and packages that are exported or temporaril
export or production, import for the purpose of research, study and testing.
- Organizations and individuals specified must register their recycling plans and report their recycling results annuall
Natural Resources and Environment.
Accept to buy 30 million doses of AZD1222 vaccine from VNVC purchased from AZ (including the number of vaccin
of Health has received for vaccination before signing the contract to buy vaccines from VNVC Company).
The Ministry of Health informed and requested units to urgently study Decision No. 2426/QD-BYT to apply. During th
process, if you have any problems, please contact the Ministry of Health (Department of Medical Equipment and Co
024.62732272, email: dmec@moh.gov.vn for consideration and solution guide.
Decision includes 04 vaccines and 10 biological products with unchanged registration numbers
To promulgate together with this Decision the list of 01 circulation number of medical equipment other than in-vitro d
equipment issued in Vietnam.
on distribution of COVID-19 vaccine AstraZeneca vaccine stage 5 to units and localities
The Ministry of Health requests businesses trading in medical equipment and consumables.
1. Review and report on the List and description of goods, medical equipment and supplies that have signed supply
period from February 1, 2019 to March 31, 2021
2. Report on the distribution, business, purchase and sale, signing of contracts for the supply of medical equipment
The Drug Administration of Vietnam received Official Letter No. 60/TTT dated April 27, 2021 from the National DI&A
suspected reaction related to phenformin-containing pills.
Phenformin is an antidiabetic drug that is no longer licensed for circulation in many countries around the world (inclu
to the risk of metabolic acidosis, even death for patients. In Vietnam, there have been cases of patients with acidosi
multiorgan failure due to phenformin poisoning mixed into preparations used for diabetes patients.
The Drug Administration of Vietnam requests the Departments of Health of the provinces and centrally-run cities to c
functional agencies to strengthen inspection and detect drug products of unknown origin, strictly handle organization
violating current regulations
Correction to presentation error under Circular No. 04/2021/TT-BYT dated April 29, 2021 of Minister of Health guidin
payment of costs of covered healthcare services
In order to have a basis to advise the Ministry of Health to develop plans and methods for receiving, storing, transpo
organizing a campaign against Covid-19 vaccine in accordance with Vietnam's conditions, Drug Administration of Vi
units to report the capacity to preserve cold products (drugs, vaccines, biological products) and the ability to preserv
vaccines when necessary according to the form issued together with this letter.
According to this document, medical equipment and accessories will be subject to 5% VAT if they have one of the fo
documents:
- Import permit;
- Certificate of marketing authorization;
- Note of acknowledgement of standard announcement documents required by legislative regulations on health;
- According to the List of medical supplies and equipment falling under the specialized management of the Ministry o
coded according to the List of Vietnam's exports and imports under the Circular No. 14/2018/TT-BYT and other docu
supplements and amendments (if any).
In order to promptly serve the prevention of the COVID-19 epidemic, it is requested that the Units urgently send a re
information required by Drug Administration in Official Letter No. 5329/QLD-KD dated 13/5/21
- Proactively detect and promptly handle suspected COVID-19 cases in business establishments and industrial park
- Ensure safe business operations and achievement of the dual targets; mitigate the pandemic’s impact on economi
social security
Adjusting distribution of the third Stage of COVID-19 vaccine AstraZeneca according to Decision 2499/QĐ-BYT
- Issued together with this Decision "Standard for data connection of information technology application software for
distribution establishments"
- This Decision replaces Decision No. 330/QD-QLD dated May 22, 2019
Adjusting distribution of the third Stage of COVID-19 vaccine AstraZeneca according to Decision 2499/QĐ-BYT
- For vaccines that have been approved by WHO for emergency using list, the Ministry of Health will consider and ap
5 working days.
- With vaccines approved by other countries but not yet approved by WHO for emergency using list, the Ministry of H
and approve them within 10 working days.
- The National Institute for Quality Control of Vaccines and Biologicals (NICVB) issues the released certificate within
recommended
03 byCovid-19
areas to treat WHO to ensure
patientsquality.
include:
Area 1: 20 beds to treat 20 asymptomatic and mild Covid-19 patients.
Area 2: 20 beds to treat 20 moderate Covid-19 patients.
Area 3: 20 beds in the intensive care unit, treating 20 severe and critical Covid-19 patients
The Ministry of Health shall update and promptly notify the list of biological products/medical equipment for in-vitro d
CoV-2 virus testing that have been granted circulation registration numbers or granted import permits including infor
manufacturers and import units so that the Departments of Health and Hospitals and Research Institutes can activel
have a procurement plan to serve the needs of epidemic prevention and control under the direction of the Governme
guidance of the Ministry of Health (Appendix attached - the list will continue to be updated as more information beco
To ensure the safe and rational use of drugs. The Drug Administration of Vietnam recommends the implementation.
- Inform health workers about information related to the safety and effectiveness of quinolone and fluoroquinolone a
- Strengthen monitoring, detection and handling of cases of adverse reactions. Send adverse reaction reports to the
for Drug Information and Adverse Reactions Monitoring or the Regional Center for Drug Information and Adverse Re
according to the form provided in Circular 23/2011/TT-BYT
Distribution of the third Stage of COVID-19 vaccine AstraZeneca
The Covid-19 vaccines have been licensed for use in the world to date have different storage conditions at different
Capability of cold chain systems in expanded immunization can guarantee the transportation and storage of vaccine
conditions at temperatures from 2oC to 8oC, but the capacity to preserve vaccines at deep negative temperatures (f
80oC to -60oC ; from -50oC to -15oC; ≤ -18oC;) is limited.
In order to soon have a basis to assess the ability to import and provide storage services for COVID-19 vaccines, th
Administration of Vietnam - the Ministry of Health proposes that units take the highest responsibility for epidemic pre
Issued together
control, urgently with this Decision
provides is aaccording
information list of 18 products
to the attached Appendix I of this letter.
To promulgate together with this Decision a form of general technical dossier on medical equipment in accordance w
regulations, to be applied in the application for free-sale registration number for class B, C, and D medical equipmen
This Decision take effect from signing date.
Issued together with this Decision is a list of 01 in-vitro diagnostic medical equipment to determine RNA of the SARS
a registration number for COVID-19 epidemic prevention. The registration number is valid for 12 months from the da
Issued together with this Decision is a list of 01 in-vitro diagnostic medical equipment to determine RNA of the SARS
a registration number for COVID-19 epidemic prevention. The registration number is valid for 12 months from the da
List of first price negotiations on April 8, 21 attached with 72 drugs of 27 active ingredients.
The suggestions and proposals in writing or soft files should be sent to the Drug Administration of Vietnam or via em
quanlychatluongthuoc.qld@moh.gov.vn before 15/05/2021
Issued together with this Decision "Guidelines for the diagnosis and treatment of COVID-19 caused by a new strain
(SARS-CoV-2)"
Issued together with this Decision Guidelines for the diagnosis and treatment of thrombocytopenia and thrombocyto
after vaccination against COVID-19.
Adjusting distribution of the second Stage of COVID-19 vaccine AstraZeneca according to Decision 1821/QĐ-BYT
Announce together with this Decision 01 newly issued administrative procedure (Certificate of free sale (CFS) for co
domestically produced for export)
and 01 amended and supplemented administrative procedure (Issue the receipt number of notification of cosmetic p
Adjusting distribution of the second Stage of COVID-19 vaccine AstraZeneca according to Decision 1821/QĐ-BYT
Drug Administration of Vietnam officially implements the webtool of announcing excipients and capsules by online fo
at: https://dichvucong.dav.gov.vn/ from the date of signing this official letter
Drug Administration of Vietnam officially implements the webtool of announcing excipients and capsules by online fo
at: https://dichvucong.dav.gov.vn/ from the date of signing this official letter
This Decree provides for administrative violations, sanctioning forms, sanctioning levels, remedial measures, compe
records, competence to sanction administrative violations in the cultural and advertisement domain
Registrars will implement this procedure on portal https://dichvucong.dav.gov.vn from the signing date of this official
electronic approval letter.
Standardize the evaluation and approval process of dossiers applied for importe license of Covid-19 vaccines witho
urgent needs for epidemic prevention and control specified in Clause 2, Article 67 of Decree No. 54/2017/ND-CP.
Standardize the evaluation and approval process of dossiers applied for importe license of Covid-19 vaccines witho
urgent needs for epidemic prevention and control specified in Clause 2, Article 67 of Decree No. 54/2017/ND-CP.
Name of vaccine: Gam-COVID-Vac (other name: SPUTNIK V).
To increase supply and increase access to many safe and effective sources of covid-19 vaccines, Drug Administrati
recommends:
Drug importers continue their efforts to urgently contact and search for sources of vaccines Covid-19.
The production and research establishments continue to accelerate the research and production of Covid-19 vaccin
proactive in the domestic vaccine source.
The ASEAN Cosmetic Scientific Body (ACSB) drafted a list of substances (257 substances) considered (hereinafter
257 - attached to this document) to submit to the ASEAN Cosmetic Committee (ACC). decision about continue to u
route to use/restrict use in cosmetics for each substance named in the List.
DEVELOPMENT PRINCPLES
1. Prioritize development of pharmaceuticals industry and domestic production of pharmaceutical starting materials w
incentive policies and preferential treatment as per the law.
2. Actively attract resources for pharmaceuticals industry development, attract foreign investment in production of in
valid trademark, specialized medication for treatment, generic drugs with hi-tech dosage form, vaccine, reference bi
bioequivalent drugs.
The government prioritizes scientific research, production of new drugs, high quality herbal drugs and production of
bearing national brand names.
3. Utilize domestic herbal sources, especially unique, rare, precious herbal ingredients and herbal ingredients with h
value.
This consolidated Document is joining of Circular No. 32/2018/TT-BYT and Circular No. 29/2020/TT-BYT regulating
circulation of drugs and medicinal ingredients
Consolidated of Circular No. 06/2011/TT-BYT and Circular No. 29/2020/TT-BYT regulating cosmetic management
Correction of Section 1 of Official Letter No. 297/QLD-CL dated January 25, 2021.
NDMA accepted temporary limit not exceeding 0.032 ppm (per dose of NDMA accept a maximum of 96 nanograms/
Issued together with this Decision is a list of 01 biological valid for 03 years from signing date of this Decision.
Issued together with this Decision is a list of 01 biological valid for 05 years from signing date of this Decision. The re
is not changed.
Decision inclung list of 06 biologicals with 03 year-valid of registration number and 01 biologicals with 05 year-valid o
number
Decision inclung list of 01 biologicals with 05 year-valid and remaining the registration number
The new procedure is variation/supplementation of marketing authoriztion of drug, medicial materials - belong to var
notification
1. General objectives
Actively prevent epidemics by using COVID-19 vaccines for at-risk groups and the community.
2. Specific objectives:
- 95% of the risk subjects and the community are vaccinated with all vaccines according to each vaccine distribution
- Ensure vaccination safety when using COVID-19 vaccine.
Guidance on the preparation of legal documents for registration of free sale of domestically manufactured medical e
Draft 02nd circulars amending and supplementing a number of articles of Circular No. 15/2019/TT-BYT on drug bidd
Assign the Ministry of Health to take charge and cooperate with Ministries, agencies, and local governments in purch
receiving donated vaccines, managing and using COVID-19 vaccines in 2021 for people aged at least 18:
1. Quantity: around 150 million doses.
2. Mechanism for vaccine purchase: Undertake the procurement in special cases as prescribed in Article 26 of the L
Procurement 2013.
1. Requirements on registration dossiers:
- Herbal materials registration dossiers: prepared according to Circular 21/2018/TT-BYT
- Application for registration of semi-finished herbal medicine: prepared according to Circular 32/2018/TT-BYT.
2. Classification and publication of the list of traditional drugs and herbal medicines that have been granted circulatio
posted on the portal of DAV and YDCT. The registrars are based on the classification list of the relevant administrati
implementation
'- Import establishments shall promptly contact and continue to find out for other quality, safe and effective suppliers
To ensure the quality and safety when using of drug, Drug Adminstration has comment as follows:
- Require drug manufacturers to put into production only batches of Metformin pharmaceutical ingredients that meet
and contain NDMA impurities not exceeding the permissible limit of NDMA impurities according to the prescribed ac
ICH M7. Assessment of raw material suppliers, raw material sources. Review production process, control input mate
- Request the importing establishment to seriously conduct the assessment of the supplier. Import only qualified bat
Annexes of the ASEAN Cosmetic Treaty on substances used in cosmetics updated on 15.01.2021
DAV announces and upload the update of Annex of ASEAN Cosmetic Agreement about banned substance in cosm
(http://www.dav.gov.vn/Quản lý mỹ phẩm):
To request FIEs to notify in writing to Ministry of Health (Drug Administration of Vietnam) the wholesalers to distribut
drugs and medicinal ingredients into Vietnam before selling or stopping selling drugs, medicinal ingredients
To amend the above circulars, Drug Administration of Vietnam suggests units to report difficulties in the process of i
circular and propose amendments and supplements (if any)
The new system for deploying procedures: https://dichvucong.dav.gov.vn/Phòng đăng ký thuốc/Xác nhận nội dung t
(TT-52) or Xác nhận nội dung quảng cáo thuốc (TT-53).
DAV will stop receiving dossier on the old system from Feb 01, 2021.
General Department of Customs answers a number of related questions: Import tax refund process; Tax incentives
Minor variation only require notification; Wet-ink signature is required on COA of drugs or medicinal ingredients;
Proposing circular 01 ways to label drugs, drug raw materials.
Ministry of Health requests the General Department to consider and direct the Customs Sub-Departments to accept
electronic signature of the manufacturer in accordance with current regulations.
Thông tư này quy định danh mục trang thiết bị tối thiểu của trạm y tế tuyến xã
Circular 30/2020/TT-BYT dated December 31, 2020 detailing and guiding measures to implement a number of articl
146/2018/ND-CP detailing and guiding implemented measures regulations of the Law on Health Insurance
Thông tư này sửa đổi, bổ sung điều 5 thông tư 05/2015/TT-BYT ban hành danh mục thuốc đông y, thuốc từ dược li
học cổ truyền thuộc phạm vi thanh toán của quỹ bảo hiểm y tế
This circular allows for continuing 1 year extension for drugs with MA licenses expired from 1/1/2018 until 31/12/202
date from Jan 01, 2021.
There are some other points to be revised: Minor variation as Notification, CPP verification, CPP content, number o
registration dossier, GMP assessement for tender, GMP of manufacturers for excipients in MA application.
The Ministry of Health informs the units to regularly monitor the progress of appraisal of registration dossiers on the
service system; carefully study the instructions on applying for registration; check the components of the submitted a
update when the documents have expired; Some other requirements related to supplementing registration documen
medical devices...
Promulgating 10 national technical standards for food additives
The decision include: list of 116 drugs with 05 year-valid registration number, list of 15 drugs with 03 year-valid regis
The issuance decesion was corrected: issuance 4, issuance 5, issuance 9, issuance 10, issuance 13, issuance 14, i
issuance 16, issuance 17, issuance 18, issuance 19, issuance 20, issuance 21, issuance 22, issuance 23 and issua
Fees in the medical field: equal to 70% of the fee rate specified in Article 1 of Circular No. 11/2020/TT-BTC dated Fe
amending and supplementing a number of articles of Circular No. 278/2016/TT -BTC dated November 14, 2016.
Fees in food safety and hygiene: equal to 90% of the fee rate specified in the Tariff for food safety and hygiene issue
Circular 75/2020/TT-BTC dated August 12, 2020 of the Minister of Finance amending and supplementing a number
Circular No. 279/2016/TT-BTC dated November 14, 2016
Ministry of Health recommended units:
- Proactive on suppliers of raw materials, improve production capacity.
- Fully comply with the law provisions on classification, standard announcement, registration for circulation, announc
and sale eligibility.
- Seriously require publicity and update of medical equipment prices.
The Drug Administration of Vietnam requires drug manufacturing and registration establishments:
1. When submitting an application for registration of circulation of clay-based anti-diarrheal drugs (eg, the active ingr
diosmectite), it is necessary to add heavy metal criteria to the specification of drug products.
2. For clay-based anti-diarrheal drugs (eg the active ingredient diosmectite) which are still valid with circulation regis
Expeditiously add heavy metal criteria to the standard of drug products.
- Stop receiving and reviewing applications for import licensing and application for issuance, renewal and maintenan
- For drugs which are still valid of MA, request the drug manufacturer or registration establishment to provide clinical
safety and efficacy of the drug. After 01 year from the date of signing this Official Letter, on the basis of clinical data
and effectiveness of the drug, the Drug Administration of Vietnam will report to the Council for consideration of the c
drug.
- For drugs which have been manufactured or imported into Vietnam within the duration of their import licenses or va
circulate until their expiry date.
- Stop receiving and approving applications for import licenses, applications for issuance, renewal, and maintenance
drug registration number.
- For drugs that is manufactured or imported into Vietnam within the duration of the import license or the valid MA al
until the expiry date of the drug.
Stop receiving and reviewing applications for import licensing, application for issuance, renewal, and maintenance M
containing fenspirid.
The decision include 40 imported drugs with 05 year-valid registration number and 14 imported drug with 03 year-va
number
This is process of appraisal of application for drug information/drug advertisement of DAV on the online portal
https://dichvucong.dav.gov.vn
Issued together with this Decision is the List of 01 foreign HIV/AIDS drug that can be extended for circulation registr
The registration number is remaining and has 05 year valid
Restricting the use of and informing medical establishments, pharmaceutical businesses and local people of informa
safety and efficacy of drugs containing mephenesin as annexed attachment.
Implement and guide local medical establishments to strengthen monitoring, detecting and handling adverse reactio
Issued together with this Decision is a list of 23 biologicals, valid for 03 years from the date of signing
Decision inclung list of 02 biologicals with 05 year-valid from signing date and remaining the registration number.
In order for the implementation of Circular No. 14/2020/TT-BYT to ensure accuracy and consistency, the Ministry of
number of specific contents such as:
- The identification of products and goods as medical equipment.
- Products not subject to bidding under Circular 14.
- Classification of medical equipments.
- Regulations on organizations and individuals providing medical equipment.
- This Decree provides for acts of administrative violation, forms, levels of sanctions, remedial measures for each ac
violation, competence to make records, competence to sanction administrative violations, according to each position
violations in the health sector
*- This Decree comes into
The announcement force 03
includes: from November 15, 2020.
annexes:
Decree1:No.
- Annex List176/2013/ND-CP
of manufacturersdatedmeetNovember
GMP: 15414, 2013 of the Government on sanctioning of administrative violati
manufacturers
-sector
Annexceases
2: List to
of be fully effectiveare
manufacturers since November
revised 15, 2020.
information compare to previous lists: 36 manufacturers
- Annex 3: List of manufacturers need supplementation, explanation: 135 manufacturers
The Ministry of Health recommends that organizations and individuals specified in Clause 6, Article 7, Circular 14/20
July 10, 20202 have to post up prices of medical equipment on the portal. electronic system of the Ministry of Health
complete before December 31, 2020
The General Department of Customs shall intensify the inspection of imported drugs and medicinal ingredients to so
problems in resolving customs procedures to ensure compliance with the provisions of Decree No. 54/2017/ND-CP
of the Government detailing a number of Articles and measures to implement the Law on Pharmacy (amended and
the Government's Decree No. 155/2018/ND-CP dated November 12, 2018) ).
Purpose
Localize and isolate the entire area with reported confirmed COVID-19, thoroughly suppress the spread of the pand
pandemic from spreading in the community and to other regions or localities.
Scope
Households living in separate houses: detached houses, semi-detached houses, villas on residential land in neighb
areas, and rural areas (hereinafter referred to as households).
This Circular is consolidated by Circular No. 279/2016/TT-BTC, Circular 117/2018/TT-BTC and Circular 75/2020/TT-
rates, collection, payment, and management. management and use of fees in food safety and hygiene
This Circular provides for the issuance and assessment of the satisfaction of good pharmacy practices.
Inspection contents
a) Inspect the compliance with regulations on subjects, rates and methods of payment by the participants of health i
b) Inspect the implementation of regulations on the entitlement to health insurance;
c) Inspect the implementation of regulations on organization of medical examination and treatment (curative care) un
insurance;
d) To inspect the implementation of regulations on medical examination and treatment contracts; medical examinatio
procedures of health insurance; health insurance assessment;
dd) Inspect the implementation of regulations on medical care cost payment between the social insurance agency a
facility;
e) To inspect the implementation of regulations on direct payment of medical examination and treatment costs betw
insurance agency and the insured.
The guidelines for COVID-19 vaccine research, clinical trials, marketing authorization and use promulgated together
are applicable during the COVID-19 pandemic.
-Announce together with this Decision 01 newly issued administrative procedure ( Granting a certificate of eligibility f
business with a bioequivalence trial scope of the drug) specified in Circular No. 10/2020/TT-BYT dated 11/6/2020 gu
bioequivalence studies
- Circular amend some articles of Circular 35/2016/TT-BYT
-This Circular comes into force from August 10, 2020
- From 1st August 2020 onwards, applicants, manufacturers of drugs and drug materials shall submit registration do
procedure 90 and procedure 89 on the Online public service system before submitting the hard copy of registration d
Stop Department of Drug Administration of Vietnam.
- From 1st July 2020 onwards, Drug Administration of Vietnam has begun to inform the validation results of drug reg
for renewal registration (procedure 90) and new registration (procedure 89) by e-document on the Online public ser
- This Circular provides regulations for the evaluation of eligibility for drug bioequivalence study facilities;
- Guiding to bioequivalence testing of drugs, dossiers and procedures for bioequivalence testing of drugs.
- This circular takes effect from August 10, 2020
Guidance on release of vaccines and biologicals used as a basis for guiding pre-circulation testing activities for vacc
biologicals being serum containing antibodies, derivatives of human blood and plasma
- This Circular promulgates list of prohibited and restricted active ingredients in insecticidal and microbicidal prepara
and medical use.
- This Circular is applicable to regulatory bodies, organizations and individuals involved in trade, manufacturing and
authorization of insecticidal and microbicidal preparations for household and medical use in Vietnam and relevant or
individuals.
- This Circular takes effect from August 20, 2020
- For the drug that license expire before 30 Jun 2020: Drug Administration of Vietnam is continuing tensely resolve o
- For the drug that license expire after 30 Jun 2020:
+ To shorten resolve timeline, Ministry of Health (Drug Administration of Vietnam) had tensely built and implemented
Service System to acknowledge, evaluate and resolve extension visa license application.
+ Drug Administration of Vietnam is tensely implementing SOps to assure granting license valid 5 years before licen
Through the process of reviewing and evaluating dossiers of registration for circulation of domestic medical equipme
C and D, the Ministry of Health faces many difficulties due to incorrect declaration procedures or has not yet been p
prescribed.
The Ministry of Health recommends the units:
- Studying fully, firmly grasping the regulations on dossier requirements, procedures according to decrees 36, 169 a
instructions.
- Actively review the declared information on the system.
- Repeat procedures for circulation registration for some cases of false declaration of procedures.
- Completing the application of ISO 13485: 2016 management system before January 1, 2020
Guidline includes:
- Recommendations on prevention and of psychological trauma during COVID-19 epidemic.
- Detection and handling of primary psychological disorders of individuals suspected to have been infected or infecte
- Management and treatment of mental illnesses.
- The list is supporting for medical establishments proactively contact, plan procurement to meet the needs of disea
control under the direction of the Government and the guidance of the Ministry of Health
- The list includes 04 domestic products and 05 imported products
- List of manufacturers meet requirements to be announced to meet GMP-EU, PICs standards: 118 manufacturers.
- List of manufacturers do not meet requirements for announcement to meet GMP-EU, PICs standards: 26 manufac
- List of manufacturers not yet met requirements and request to supplement: 64 manufacturers.
This Decision issued together with document “Temporary guideline on selecting and using facemask in COVID-19 p
prevention”.
This Decision becomes valid from the signing date of issue
-The list including manufacturers from version 28 to version 68 (according to Circular 11) which meet the requireme
List of 04 units of quality inspection/testing of diagnostic bio-product/in-vitro diagnostic medical devices for testing C
(SARS-CoV-2):
1. The Central Institute of Hygiene and Epidemiology
2. Ho Chi Minh City Pasteur Institute.
3. Nha Trang Pasteur Institute.
4. National Institute for Control of Vaccines and Biologicals
The issuance of import licenses and domestic production registration numbers for SARS-CoV-2 diagnostic test kits:
- For Imported test kits for sponsorship or aid:The composition of import dossier specified in Article 42 of Decree 169
- For domestic production test kit: The components of dossier are specified in Article 26 of Decree 169/2018/ND-CP
- For imported test kit to trade:
+ For test kits used with medical equipment: comply with the Circular No. 30/2015/TT-BYT
+ For independent use test kits: the composition of import dossier specified in Circular No. 47/2010/TT-BYT
The Ministry of Health encourages and supports research and production research units to import, sponsor, and aid
SARS-CoV-2 medical devices such as chemical used with PCR machines, test strips/fast test trays…
- The issuance of import licenses and domestic production registration numbers for SARS-CoV-2 diagnostic test kits
implemented by the Ministry of Health.
- In case products with CFS show that the products are circulated in the producing country or CFS issued country, th
allowed to import a number of samples to test at the quality testing unit designated by the Ministry of Health. Based
results of the quality testing unit and the import application dossier of the unit, the Ministry of Health shall issue a qu
- In case the legal documents in the import dossier are not consular legalized: please request the official letter comm
responsible for the authenticity, commit time to providing consular legalization, and at the same time provide a link to
licenses or contact the licensing agency for the Ministry of Health to check the authenticity of papers not yet consula
- List of criteria for evaluation of GMP assessment dossier.
-Consolidated document Decree 36/2016, Decree 169/2018, Decree 03/2020 by The Gorvenment on Medical Equip
The DAV requested to Health Departments of provinces, Hospitals and institutes with beds under the Ministry of Hea
sectors, to review, plan medicine items, update list of essential medicine, develop a plan to store and coordinate dru
complicated epidemic developments to avoid passivity and drug shortages. Continuously monitor the epidemic situa
statu.
1. Testing purposes
- Diagnosis of infection with SARS-CoV-2
- Epidemiological surveillance of COVID-19
2. Testing principles
- Laboratories must comply with clinical test procedures and approaches according to instructions given by diagnost
warnings of WHO/USCDC.
- Testing quality and biosafety must be assured.
3. Testing techniques
- Molecular biotest (Realtime RT-PCR) which is used for detecting coronavirus ARN from respiratory samples.
- Quick tests on clinical respiratory and blood samples.
- Immunological tests (ELISA, etc.) on clinical respiratory and blood samples.
The Drug Administration of Vietnam requires the Department of Health and hospitals to notify medical examination a
establishments in the area "the list of drugs and the list of establishments manufacturing and importing drugs" for the
control of the Covid-19 epidemic to prevent and control the Covid-19 epidemic. Promptly and proactively contact dru
and importers to ensure that there are enough drugs to meet the treatment needs of these establishments.
The DAV requested to manufacturers, the import and export units to increase the supply of drugs and medicinal ma
a production plan to ensure the supply of situations where 10,000 people have COVID-19.
Request the units to report the amount of inventory. Apply online reports on the portal https://duocquocgia.com.vn
Issued together with this Decision the list of equipment, consumables and essential drugs of 01 COVID-19 patient is
area
The Highlight:
- In case label of products does not contain full compulsory information regulated under Decree 43/2017/ND-CP, cus
do not fine enterprises.
- Including 14 products requested supplemented documents
- List of manufacturers meet requirements to be announced to meet GMP-EU, PICs standards: 74 manufacturers.
- List of manufacturers do not meet requirements for announcement to meet GMP-EU, PICs standards: 22 manufac
- List of manufacturers not yet met requirements and request to supplement: 25 manufacturers.
-The list including manufacturers from version 28 to version 68 (according to Circular 11) which meet the requireme
Implementation schedule
1. Pilot phase: From the date of signing this Decision to June 30, 2020.
2. After the pilot phase: Officially implementing level 4 online public services for procedures for licensing drug import
registration certificate for circulation in Vietnam
In order to have general information about the supply capacity of units for drugs in the Appendix attached to Official
939/QLD-DK, the Drug Administration of Vietnam requires units to report inventory quantities, status of production a
epidemic drugs according to the report form.
- The list including manufacturers from version 28 to version 70 (according to Circular 11) which meet the requireme
- Revised some articles: Article 1, Clause 1 Article 7, Point c Clause 3 Article 7, Clause 6 Article 7.
- The revision related to some points:
+ Apply quality standards in quality control of drugs and drug raw materials.
+ Archiving records and documents
+ Designate GLP-compliant testing facilities to carry out pharmaceutical product tests specified in Clause 1 of this A
+ Adding Point d is added to Clause 6 of Article 8: Select a testing facility that satisfies the regulation laid down in Po
this Article so that samples are sent to such testing facility.
Highlights:
- In case the label of imported goods does not have a label as prescribed by law, customs authorities shall base on
Clause 7, Article 14 of Decree No. 127/2013 / ND-CP to sanction.
- In case the import goods label does not contain all compulsory contents as prescribed in Decree 43, the customs a
on the provisions at Point a, Clause 1, Clause 2, Article 31, Article 37 and Clause 4. Article 42 of Decree 119/2017/N
Including List of 46 APIs with corresponding strength must plan for epidemic prevention
In order to ensure sufficient supply of drugs and stabilize prices, avoid hoarding and increase drug prices, to serve d
and control in Vietnam, the Drug Administration of Vietnam requires the following units:
- Departments of Health: instruct local units to proactively plan to prepare enough drugs for level 3 and get ready for
inspection of drug business establishments in the locality to avoid speculation and hoarding goods to take advantag
to increase drug prices.
- Hospitals: proactively plan to prepare enough drugs; timely update the guidance on diagnosis and treatment of dise
Ministry of Health to add drugs to the procurement plan.
- Drug manufacturing, trading and importing units: proactively grasp actual demand, increase supply and develop pla
and trading of drugs to serve the treatment needs of medical examination and treatment facilities.
- Stop receiving application dossier for registration, import, extension and renewal of registration numbers.
- The above-mentioned drugs are still valid for circulation and require establishments providing clinical studies
- For drugs which have been manufactured and imported, they may be circulated until the expiry date (within the tim
import permits and circulation registration certification).
- Application dossier for import, registration, extension, renewal: request for the supply of origin of formulas accordin
2396 and scientific evidence for the contents of the Leaflet, or clinical data.
- For manufactured and imported drugs, they are circulated until the expiry date (within the time limit on the import li
circulation registration certification).
- Stop receiving import, registration, extension, renewal. - - For drugs which have been manufactured and imported
circulated until the expiry date (within the time limits on the import permits and circulation registration certification).
- The above-mentioned drugs are still valid for circulation and require establishments providing clinical studies.
- For drugs which have been manufactured and imported, they may be circulated until the expiry date (within the tim
import permits and circulation registration certification).
List of Decision having updated information includes: version 4, 5, 7, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 20, 21, 22
In order to apply online to acknowledge, resolve submitted registration dossier to DAV (1st time registration) by hard
granting license, DAV inform and request Applicants, manufacturers to implement upload dossier to online system o
Request applicants to upload to Online system for registration application that submitted hard copy directly at DAV b
The highlight:
- The license for import of medical equipment of Class B, C, D and the license for import of in-vitro diagnostic biolog
issued in 2018, 2019, 2020, 2021, the above licenses are valid until by December 31, 2021.
- For Class A medical equipment with receipt of application for announcement of applicable standards issued by the
Health, It is allowed to import according to demand, unlimited quantity without classification and identification docum
admitted
The to be medical equipment by the Ministry of Health when carrying out customs clearance procedures.
highlights:
-For
Forgoods
medical equipment
imported not on the
into Vietnam andlistthe
of original
productslabels
subjectdo to
notimport licensing
comply with theand having the
provisions classification
of Decree 43, theasimportin
medic
categories
and individuals must carry additional labels according to the provisions of Clause 3, Article 7 and Clauses 3 andwill
B, C and D, by the classification organization who announced on e-portals by the Ministry of Health 4, cA
imported until the end of December 31, 2021 as demand, unlimited quantity
Decree. This label must be kept in original condition before being put into circulation without classification and identification d
admitted toifbe
Therefore, themedical
goods equipment by the
at the customs gateMinistry
are notoffully
Health whenwith
labeled carrying out customs
Vietnamese clearance
contents procedures
according to regulations,
determined as a violation of goods label.
Covid-19 Vaccine
Molnupiravir,
Covid-19, Favipiravir,
Import-Export Baricitinib, 2-Deoxy-
D-Glucose
Cosmetic
Medical Devices
Product Code
Molnupiravir,
Remdesivir,
Sotrovimab,
Baricitinib, 2-Deoxy D
Glucose (2-DG),
Covid-19
monoclonal antibody
Molnupiravir,
duos: Casirivimab
Remdesivir,
and Imdevimab,
Sotrovimab,
Bamlaivimab
Baricitinib, and D
2-Deoxy
Etesevimab
Glucose (2-DG),
Covid-19
monoclonal antibody
duos: Casirivimab
and Imdevimab,
Bamlaivimab and
Drugs Quality Etesevimab
Management
Import-Export Custom Clearance
Connecting
Trading Management distribution facilities,
retail facilities
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Medical Devices,
Covid-19
Covid-19, Health
Inssurance
Administrative
Vaccines
Procedure, Covid-19
Guideline for testing,
Covid-19
diagnose and
prevention Covid-19
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
SOP DAV
Covid-19
Vaccines
Banned substances
Antiseptic
in Antiseptic
Registration, Covid-
19, Vaccines
Draft regulations
SOP DAV
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
SOP DAV
Covid-19
Draft regulations
Draft regulations
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Covid-19
Covid-19
GLP, GMP
Draft regulations
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Covid-19
SOP DAV
Covid-19
Draft regulations
References, SRA,
PIC/s, ICH list
Regulating
Cosmetic
substances used in
cosmetics
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
SOP DAV
SOP DAV
Banned substances
Food Supplement in food production
and trading
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Tender
Draft regulations
List of reference
authorities
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Health Insurance
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Connecting
Trading Management distribution facilities,
retail facilities
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
BA/BE
Tender
announcement
GSP
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
Quinolon,
Warning on APIs
fluoroquinolon
Draft regulations
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
BE
Health Insurance
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Cosmetic, SOP
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Administrative
sanctions,
Advertisement &
Symposium
DRUG
Drug registration
Covid-19
SOP DAV
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
Regulating
Cosmetic Registration substances used in
cosmetics
Pharmaceutical
industry development
program
Cosmetic Registration
Update information
of APIs when
registration,
production, import-
export, circulation in
VN
SOP
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Medical Device
Draft regulations
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Tradditional
Medicine,
Administrative
Procedure
Covid-19
Purchase, receipt,
Covid-19 storage, distribution
and use of Covid-19
vaccines
Medical Device Registration
Draft regulations
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
Update information
of APIs when
registration,
production, import-
export, circulation in
VN
Regulating
Cosmetic substances used in
cosmetics
Regulating
Cosmetic Registration substances used in
cosmetics
Draft regulations
Trading Management
Pharmacovigilance
Advertisement &
Symposium
DRUG
REFERENCES
REFERENCES
Medical Device
Medical Device
Medical Device
Medical Device
DRUG
DRUG
DRUG
Covid-19
Covid-19
salbutamol,
Warning on APIs
guaifenesin
DRUG
MEDICAL DEVICES
FOOD
DRUG
SOP, Advertisement
& Symposium
Tender Branded
announcement
Tender Branded
announcement
Medical Device
Administrative
sanctions
Tender GMP assessment
Draft regulations
Administrative
sanctions
Medical Device
Draft regulations
Covid-19
Covid-19
Fee for
Administrative
Procedure
GPP
Draft regulations
Health Insurance
Covid-19
Draft regulations
Draft regulations
GMP
Draft regulations
SOP
Health Insurance
GPP
GLP
GDP
Draft regulations
SOP
Draft regulations
Medical Device
Draft regulations
Fee for
Administrative
Procedure
Draft regulations
Draft regulations
Draft regulations
BE Trial
Draft regulations
Vaccine
Antiseptic
Temporary Visa
Registration & SIQ
extension
Medical Device
Covid-19
Medical Device
Draft regulations
Draft regulations
Tender Branded
announcement
Tender GMP-PICS
Tender GMP-PICS
Draft regulations
Tender Branded
announcement
Tender Branded
announcement
Tender Branded
announcement
Tender Branded
announcement
Tender Branded
announcement
Covid-19
Mask for covid
Tender GMP-PICS
Medical Device
Medical Device
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
Tender GMP assessment
Medical Device
Correction
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
Covid-19
Good Labels
BE Trial
Fee for
Administrative
Procedure
Medical Device
Tender GMP-PICS
Tender
Visa decision
Visa Decision &
correction
Medical Device
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
Medical Device
Branded
Tender
announcement
Drugs Quality
Management
Good Labels
Covid-19
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
List of products
Covid-19 diagnose, prevention
and control of
COVID-19
Neomycin sulfat,
Dexamethason natri
phosphat,
Xylometazolin
Warning on APIs
hydroclorid,
Neomycin,
Dexamethason natri
phosphat
BA/BE
Tender
announcement
BA/BE
announcement
BA/BE
announcement
Medical Device
Good Labels
Medical Device,
Advertisement & Public service level 4
Symposium
Report
Cosmetic Registration
Medical Device
List of reference
authorities
List of reference
authorities
List of reference
authorities
Good Labels
List of Package
Insert of Branded
drugs
Medical Device
Medical Device
Drugs Quality
Management
National Drug
Database
Tender
Food supplement
Food supplement
Good Labels
Herbal medicine
Material
Public Service DAV
Announcement
Medical Device
Regulating
Cosmetic Registration substances used in
cosmetics
Veterinary Drug
Food supplement
Tender
SOP
Medical Device
Good Labels
Drugs Price
Management
Medical Device
Vaccine
Vaccine
Vaccine
Connecting
Trading Management distribution facilities,
retail facilities
List of business
investment
conditions
Traditional medicine
National Drug
Database
Food supplement
Antiseptic
Food supplement
Food supplement
Food supplement,
SOP
Tender
Drugs Price
Public service level 4
Management
GPP
Original of Fomular
Medical Device
Warning on APIs Cefterol
Sulfaguanidin;
Warning on APIs Ephedrin,
Nitroglycerin
Material
Public Service DAV
Announcement
Medical Device
Medical Device
Medical Device
Medical Device
Medical Device
Drugs Price
Management
Medical Device
SOP
Functions of the
Ministry of Health
Cosmetic, SOP
SOP
Health Insurance
Health Insurance
Medical Device
Fee for
Administrative
Procedure
GPP
GSP
GMP
Vaccine
Veterinary Drug
Food supplement
Health Insurance
Health Insurance
Clinical Trial
Health Insurance
Food supplement,
SOP
Cosmetic, SOP
Health Insurance
Food supplement
Food supplement
Food supplement
ETC
GPP
Rabeprazole,
Ceftezol,
Sulfaguanidin,
Ephedrin,
Nitroglycerin,
Warning on APIs Paracetamol,
salbutamol,
Carbocistein,
bromhexin, N-acetyl
cystein, amroxol,
Citicolin
Medical Device
Tender
Chymotrypsin
Warning on APIs (Alpha-
chymotrypsin)
Conditions for
pharmaceutical
business
Health Insurance
Tender
Conditions for
pharmaceutical
business
Drugs Quality
Management
Drugs Quality
Management
Conditions for
pharmaceutical
business
Tender
Antiseptic
Salbutamol,
Carbocystein,
Warning on APIs
bromhexin, N acetyl
cystein, ambroxol
Regulating
Cosmetic Registration substances used in
cosmetics
OTC
Conditions for
pharmaceutical
business
Different in ways of
Warning on APIs
writing API
Product Code
Food supplement
Product Code
Medical Device
Food supplement
FIE
GSP
GDP
Food supplement
GPP
Health Insurance
Health Insurance
ETC
Medical Device
Medical Device
Antiseptic
Tender
Medical Device
Medical Device
Mifepriston,
Warning on APIs
Misoprostol
Drugs Price
Management
National
Pharmacopoeia
Health Insurance
Clinical Trial
Fee for
Administrative
Procedure
Methylprednisolon,
Warning on APIs
Lactose
Medical Device
Medical Device
FIE
gadolinium; codein,
tramadol; hyoscine
butylbromide;
Warning on APIs
risperidone;
chlorhexidine
gluconate
Tradditional Medicine
FIE
Medical Device
Medical Device
Pharmacovigilance
Special Management
drugs
OTC
Good Labels
Pharmacovigilance
Medical Device
Tender
Tender
Import-Export
Medical Device
Medical Device
Fee for
Administrative
Procedure
Fee for
Administrative
Procedure
Fee for
Administrative
Procedure
BE Trial
Medical Device
National
Pharmacopoeia
Domperidone,
Warning on APIs Proton Pump
Inhibitor
Medical Device
Food supplement
Import-Export
Warning on APIs codein
Azithromycin,
Clozapin,
Warning on APIs
Mycophenolate
mofetil, Clopidogrel
Food supplement
Cosmetic Production
Antiseptic
Food supplement
Veterinary Drug
Veterinary Drug
Medical Device
Antiseptic
Tender
Tender
Food supplement
Pharmacy Law
OTC
Health Insurance
Clinical Trial
Food supplement
Trading Management
Medical Device
DPP-4,
Warning on APIs Methotrexate, NSAID
non-Aspirin
API announcement
Food supplement
Food supplement
Food supplement
Health Insurance
Food supplement
Medical Device
Health Insurance
Food supplement
Medical Device
Classification of
medical diseases
Drugs Quality
Management
Biphenyl dimethyl
Warning on APIs dicarboxylat,
Cefetamet
Warning on APIs
Drugs Quality
Management
Health Insurance
Pharmacovigilance
Import-Export
Advertisement &
Symposium
Medical Device
Ambroxol,
Bromhexine,
Hydroxyzine,
Warning on APIs
Hydrochloroquine,
Chloroquine,
Topiramate
olmesartan
Warning on APIs
medoxomil
Food supplement
Regulating
Cosmetic Registration substances used in
cosmetics
Health Insurance
Value added tax
GMP
Health Insurance
Food supplement
Health Insurance
Health Insurance
Health Insurance
Misoprostol ,
Warning on APIs
mifepriston
Tender
Tradditional Medicine
Humanitarian
healthcare
Health Insurance
Pharmacovigilance
Import-Export
OTC
Herbal medicine
Tender
Hydroxyethyl starch
Warning on APIs
(HES)
Insurance Law
cyproteron acetat ,
Warning on APIs
ethinyl estradiol
Special Management
drugs
Medical Device
Pharmacovigilance
Pharmacovigilance
Pharmacovigilance
Tender
Tender
bifendat, biphenyl
Warning on APIs
dimethyl dicarboxylat
Pharmacovigilance
Capecitabine,
Warning on APIs
Salbutamol
Drugs Quality
Management
Pharmacovigilance
Clinical Trial
Traditional medicine
Health Insurance
GMP
GMP
Metoclopramid,
Warning on APIs
Lysozym HCl
Advertisement &
Symposium
Import-Export
Import-Export
Advertisement &
Symposium
Administrative
sanctions
Tender
Tender
Advertisement &
Symposium
Warning on APIs strontium ranelat
Import-Export
GSP
Advertisement &
Symposium
Registration & SIQ
Drugs Quality
Management
Tender
Drugs Quality
Management
BE Trial
Tender
SOP
Trading Management
Health Insurance
Pharmacovigilance
Fee for
Administrative
Procedure
List of poisonous
herbs
GMP-PICS
Pharmacovigilance
Streptokinase,
Warning on APIs
Streptodornase
Cephalosporin, Beta-
Warning on APIs
lactamase inhibitor
drosperinone,
Warning on APIs
finasteride
Warning on APIs Strontium ranelat
Functions of the
Ministry of Health
Warning on APIs
Tender
Advertisement &
Symposium
Health Insurance
Meprobamat,
Warning on APIs
Valerian
Medical Device
Cosmetic
Registration
Clinical Trial
Tender
Drugs Price
Management
GLP, GSP
GPP
GDP
Company registration
Products of
potentially unsafe
goods under the
management of
MOH
GMP
pseudoephedrin,
Warning on APIs
triprolidin
Health Insurance
Antiseptic
Medical Device
Trading Management
GMP
GMP
special management
Warning on APIs
drugs
Cosmetic
Registration
Warning on APIs Artemisinin
Import-Export
Tradditional Medicine
Drugs Quality
Management
BE Trial
Drugs Quality
Management
Health Insurance
OTC
Pharmacovigilance
Advertisement &
Symposium
Tradditional Medicine
Fee for
Administrative
Procedure
Cosmetic, Product
Code
Import-Export
Drugs Price
Management
Tender
Trading Management
Biphenyl Dimethyl
Warning on APIs
Dicarboxylat (BDD)
GMP
Advertisement &
Symposium
Company registration
Import-Export
Clinical Trial
Medical Device
Good Labels
Pharmacy Law &
Decree detailing
Pharmacy Law
Medical Device
Import-Export
Import-Export
Advertisement &
Symposium
Pharmacy Law
GMP
Food supplement
Contract
Registration & SIQ
manufacturing
Company registration
Advertisement &
Symposium
Import-Export
Advertisement &
Symposium
Advertisement &
Symposium
Company registration
GLP